Quarterlytics / Healthcare / Uscom Limited

Uscom Limited

ucm · ASX Healthcare
Claim this profile
Ticker ucm
Exchange ASX
Sector Healthcare
Industry
Employees 11-50
← All annual reports
FY2012 Annual Report · Uscom Limited
Sign in to download
Loading PDF…
Uscom Ltd, Suite 1, Level 7, 10 Loftus Street, Sydney NSW 2000 Australia T +612 9247 4144

  L i v e s

g

v i n

S a

ANNUAL REPORT
2012

Chairmans Letter 
2 

Corporate Governance 
5 

Directors’ Report and Financial Statements 
10 

 
 
 
 
 
 
 
 
 
 
 
 
CHAIRMANS LETTER 

To fellow shareholders 

Change: This year saw a significant change in direction of the Company with a fundamental re-organisation of the 
management at the direction of shareholders at the 2011 AGM. I am pleased to report the Company results of 
the 2012 financial year, and to update investors of the objectives, activities and early results of the new Company 
strategy.  While  much  of  this  6  months  has  been  review  and  re-orientation,  we  are  confident  in  the  new  Uscom 
direction and early signs are promising. 

Strategy:  Immediately  following  the  2011  AGM  we  reviewed  operations  and  devised  a  new  strategy  with 
consideration  to  the  then  state  of  operations,  the  uncertain  global  economy,  and  the  evolving  unprecedented 
scientific recognition of the USCOM technology. The strategy focused on three points; 

1. 
2. 
3. 

Restore operational soundness - increase sales and decrease spend and preserve cash. 
Focus on incremental growth opportunities – licensing, product co-developments and transactions. 
Realise the true capital value of the technology and company – the current capitalised value of the company 
is a fraction of similar entities despite the world leading and increasingly recognised technology. 

Results: The FY 2012 results are weighed down by the poor Q1 and Q2 results of last year. However Q3 and Q4 
have responded positively as new management has revived sales and reduced costs. Total revenue for the 2012 
FY was $864k, down 2% on last year from $881k in 2011. The new cost containment strategy introduced in Q3 and 
Q4 has reduced the aggregate loss for FY 2012 by 32% from a $2.869m loss in 2011 to $1.825m in FY 2012. 

Capital: To restore capital adequacy to the Company we have undertaken a successful private placement raising 
approximately  $1m  at  12c  a  share  from  sophisticated  investors  including  both  current  and  new  investors.  The 
offer was over subscribed, with some shares offered conditional to shareholder approval and will be voted on at 
the AGM. We will also receive a research and development tax rebate of approximately $400k. This,  combined 
with  our  tightly  managed  spend,  will  ensure  capital  certainty  in  the  year  ahead  as  our  current  strategy  is 
implemented.  We  have  always  valued  capital  and  respect  shareholder’s  investments,  and  while  creating  life 
saving  technology  is  a  mission  of  our  company,  we  believe  this  good  should  be  converted  to  significant 
shareholder rewards. 
Last year the Auditor’s review of the Uscom accounts included an emphasis of matter and comments regarding 
matters of going concern. This year,  after  the  private placement  and introduction  of  new  budget  measures  the 
current financial position is much improved and recognised by an unmodified audit opinion. This reflects the new 
emphasis on controlled management and validates shareholders actions at last year’s AGM. 

Sales: It is taking time to re-motivate the previously alienated distributors, but we are seeing some up swing in 
both  opportunities  and  sales,  and  we  are  optimistic  this  trend  will  continue  as  new  international  research 
promotes new markets, and current markets begin to grow again. While sales are unlikely to be spectacular, the 
cash needs of the Company are now tightly managed and increased revenue combined with a decreased cost will 
positively effect operations and we are optimistic for the year ahead. 

Share price: The share price has more than doubled from 6c to 15c in the last 6 months on relatively high volume 
as  the  new  management  and  strategy  have  been  recognised  by  investors,  and  this  has  resulted  in  a  more 
balanced shareholder register. Uscom Limited is currently capital valued at a fraction of that of our competitors 
and  we  are  looking  forward  to  new  investor  demand  driving  the  retail  market  and  restoring  the  share  price  to 
reasonable  levels.  Additionally  the  Company  is  well  poised  to  achieve  a  significant  value  re-alignment  as  the 
implications  of  the  world  leading  USCOM  science  is  recognised  and  new  partnerships  are  completed.  The 
bioscience  sector  continues  to  gain  investor  attention  and  USCOM  science  is  unequalled  and  represents  an 
outstanding commercial opportunity, and we are now poised to realise the commercial value of the technology 
for shareholders. 

Risks:  The  risks  for  the  Company  remain  in  sales  and  marketing  in  a  particularly  difficult  market  with  limited 
resources.  Resistance  to  change  in  clinical  practice,  despite  outstanding  clinical  evidence,  also  remains  an 
impediment  to  adoption;  change  is  always  difficult  in  the  conservative  field  of  medicine.  The  strategy  of 
establishing partnerships, although promising, depends on the willingness and vision of prospective partners. 

Science:  This  year  the  non-invasive  USCOM  was  confirmed  as  the  clinical  gold  standard  cardiac  monitor  and  a 
true  platform  technology  across  multiple  applications,  an  objective  on  which  the  Company  was  founded.  
USCOM now has clinical proof in over 21 fields including paediatrics, sepsis, heart failure and hypertension, and 
the  list  is  expanding.  Each  of  these  applications  supports  a  potential  licensing  partnership  and  a  unique  and 
expansive business opportunity. The USCOM now has over 250 peer reviewed publications researching its clinical 
utility, and clinical adoption of Uscom technology continues with over 600 USCOM’s in clinical sites throughout 
the world.  

Uscom Limited - Annual Report 2012 - 2 

 
 
 
 
 
 
  
 
 
 
 
 
CHAIRMANS LETTER continued 

The scientific highlights for this year include: 

• 

Professor  Smith  at  Bathurst  has  demonstrated  a  reduced  mortality  in  management  of  sepsis  of  90% 
using USCOM. This evidence will influence clinical practice worldwide. 

•  USCOM  was  proven  in  a  study  at  The  Howard  Florey  Institute  in  Melbourne  to  be  6  to  8  times  as 
sensitive  as  the  pulmonary  artery  catheter  which  requires  a  catheter  inserted  directly  into  the  heart. 
USCOM  was  founded  to  replace  invasive  and  ineffective  technologies  with  accurate  and  non-invasive 
alternatives; this study validates that objective and separates USCOM from its competitors. 

With  the  increasing  scientific  validation,  the  pressure  for  adoption  of  USCOM  as  a  global  standard  of  care  is 
increasing. The USCOM science is now unequalled, with lives being saved weekly, if not daily, worldwide.  

Partnerships strategy: USCOM is a genuine gold standard, platform cardiac monitoring technology on the cusp 
of  commercial  recognition  and  our  new  strategy  is  to  work  with  major  medical  device  companies,  which  are 
known to USCOM, with specific market expertise and distribution channels to establish selective partnerships. It is 
envisaged  that  these  partnerships  will  be  based  on  co-development  and  distribution  relationships  and  the 
partners multi-national organisations with sales and marketing scale and reach with sector specific  focus. These 
partnerships are expected to add cost effectively to revenue and add incremental capital value to the Company. 
The increasing scientific recognition will drive USCOM into many new markets, all of which will require strategic 
partnerships  to  adequately  capitalise.  A  single  strong  partnership  has  the  potential  to  make  the  company 
profitable  immediately.  Current  partnership  opportunities  include  licensing  USCOM  technology  into  ultrasound 
devices, cardiac monitoring modules, ventilators, pacemakers and artificial hearts, pharmaceutical companies for 
guidance  and  optimisation  of  drugs  for  heart  failure,  hypertension  and  chemotherapy,  and  home  care 
management.  This  will  result  in  specialised  USCOM  devices  for  paediatrics,  sepsis,  heart  failure,  hypertension, 
electrophysiology, cardiac monitoring, and include our new cardioCARE management guidance software. 

Conclusion: Uscom is doing genuinely important work; changing clinical practice and saving lives. Uscom remains 
a great Company with great technology and great people, poised to transition to a powerful multi-product and 
profitable global bio-device Company. I am proud of what we have done, excited about what we hope to do and 
delighted to have you as investors in Uscom Limited to share in the success as we improve global medical care 
and refine operations with a new strategy and company vision. I believe we can look forward to the coming year 
with  optimism  as  we  pursue  the  milestones  which  will  incrementally  grow  the  value  of  Uscom  and  reward 
investors. 

Thank you. 

Rob Phillips 
Executive Chairman 
Uscom Limited 

Uscom Limited - Annual Report 2012 - 3 

 
 
 
  
 
 
 
 
 
USCOM - SAVING LIVES 

Uscom Limited - Annual Report 2012 - 4 

 
 
 
 
 
 
 
 
CORPORATE GOVERNANCE STATEMENT 

As outlined in previous annual reports, Uscom is committed to continuing its high standards of corporate 
governance. Effective corporate governance aids the Company to set and achieve its objectives. Our Governance 
Statement for 2011/2012 outlines our policies and practices by reference to the Corporate Governance Principles 
and Recommendations with 2010 Amendment published by the ASX Corporate Governance Council (“ASX 
Principles”). 

Principle 1: Lay solid foundations for management and oversight 
Recommendation 1.1: Establish the functions reserved to the board and those delegated to senior 
executives and disclose those functions. 
The Board has adopted a charter that sets out the responsibilities reserved by the Board, those delegated to the 
Executive Chairman.  For a copy of the Board Charter refer to Uscom Corporate Governance Documentation on 
the Company website. 

Recommendation 1.2: Disclose the process for evaluating the performance of senior executives. 
The Chief Executive Officer and General Manager attend the scheduled board meetings and present to the 
Board regarding the Company’s performance against its goals and objectives. The Board assesses the 
performance of the Senior Executives against their individual goals and objectives and those of the Company on 
a regular basis at these meetings. The Company conducts annual performance appraisals of all employees. 

Recommendation 1.3: Provide the information indicated in the Guide to reporting on Principle 1. 
A performance evaluation of Senior Executives has taken place during the reporting period in accordance with 
the process disclosed above.  A copy of the Board Charter is included with the Uscom Corporate Governance 
Documentation on the Company website. 

Principle 2: Structure the board to add value 
Uscom Ltd has the services of a Board with a wide range of professional experience in fields such as science, 
medicine, marketing and international business.  Further information regarding the Directors is provided in the 
Directors’ Report (refer to page 10). 

Recommendation 2.1: A majority of the board should be independent directors. 
The Board consists of three members, two of whom are Non-Executive Directors. The Company takes the view 
that the two Non-Executive Directors are also Independent Directors. In the interests of transparency, the  
Company discloses relationships or business associations which may impact a person’s own interpretation of the 
definition of independent. 

The Board believes that the composition is appropriate for the Company due to its small size and the nature of 
the business.  The Board will continue to review this on an ongoing basis. 

Recommendation 2.2: The chairperson should be an independent director. 
The Chairman of Uscom Ltd, Mr Rob Phillips, is an executive director and is therefore not an independent 
director. The Board believes that an Executive Chairman is appropriate given the size of the Company and the 
nature of the business.   

Recommendation 2.3: The roles of chairperson and chief executive officer should not be exercised by the 
same individual. 
Mr Rob Phillips is the Executive Chairman and Chief Executive Officer.  The Board believes this is appropriate 
given the size of the Company and the nature of the business.   

Recommendation 2.4: Establish a nomination committee. 
The Company believes that a nomination committee is not necessary at this stage of the Company’s 
development.  Issues relating to board membership will continue to be overseen by the full Board. The  
Company believes this to be justified given the relatively small size of the board and that significant growth in the 
number of Directors is not envisaged in the medium term. 

Recommendation 2.5: Disclose the process for evaluating the performance of the board, its committees 
and individual directors. 
A director’s performance is evaluated informally by assessing their contribution and attendance at all Board 
meetings. 

Uscom Limited - Annual Report 2012 - 5 

 
 
 
 
 
 
 
 
 
 
 
 
 
CORPORATE GOVERNANCE STATEMENT continued 

Recommendation 2.6: Provide the information indicated in the Guide to reporting on principle 2. 
• 

The skills, experience and expertise relevant to the position of Director held by each director in office can be 
found in the Directors’ Report. 
The names of the Directors considered by the Board to constitute Independent Directors and the Company’s 
materiality threshold can be found in the Directors’ Report. 

• 

•  All Company Non-Executive Directors are considered independent, notwithstanding the existence of 

relationships stated in the Guide. 
The term of office held by each Director in office can be found in the Directors’ Report. 

• 
•  As set out above, the Company believes that a nomination committee is not necessary at this stage of the 

Company’s development therefore does not hold nomination meetings. 

•  A statement detailing the procedure agreed by the Board for Directors to take independent professional 

• 

advice at the expense of the Company can be found in the Remuneration Report. 
The Board’s membership and structure is selected for optimum efficiency while providing high levels of 
expertise in science, medicine and business.  The Board as a whole considers nomination issues, including 
the mix of skills and diversity of the Board, in an ongoing, informal manner.  As stated above the Board is not 
looking to significantly expand its membership in the medium term.  

•  A formal performance evaluation for the Board, its committees and Directors has not taken place in the 

reporting period however performance is measured as described in 2.5 above. 

Principle 3: Promoting ethical and responsible decision-making 
Recommendation 3.1: Establish a code of conduct to guide the Directors, the Chief Executive Officer and 
other key Executives as to: 
• 
• 

The practices necessary to maintain confidence in the Company’s integrity. 
The practices necessary to take into account their legal obligations and the reasonable expectations of 
their stakeholders. 
The responsibility and accountability of individuals for reporting and investigating reports of unethical 
practice. 

• 

The Company has developed a Code of Conduct for Directors, management and staff, underlining the 
Company’s commitment to high ethical standards in the conduct of the Company’s business. The Board is 
responsible for ensuring the Company’s compliance with the Code and the good and fair management of reports 
of any breaches. 

For detailed Code of Conduct refer to Uscom Corporate Governance Documentation on the Company website. 

Recommendation 3.2: Establish a policy concerning diversity and disclose the policy or a summary of that 
policy.  
The Company has adopted a policy in relation to diversity.  For details refer to Uscom Corporate Governance 
Documentation on the Company website. 

Recommendation 3.3: Companies should disclose in each annual report the measurable objectives for 
achieving gender diversity set by the board in accordance with the diversity policy and progress towards 
achieving them. 
The Company has not established measurable objectives for achieving gender diversity at this time. 

Recommendation 3.4: Companies should disclose in each annual report the proportion of women 
employees in the whole organisation, women in senior executive positions and women on the board. 
The proportion of women within the organisation is: 42% 
Women within whole organisation:                  
Women in senior executive positions:           
Women on the board:                                    

5 
8% 
1 

Recommendation 3.5: Companies should provide the information indicated in the Guide to reporting on 
Principle 3. 
Information can be found in the Uscom Corporate Governance Documentation on the Company website. 

Uscom Limited - Annual Report 2012 - 6 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CORPORATE GOVERNANCE STATEMENT continued 

Principle 4: Safeguard integrity in financial reporting 
Recommendation 4.1: Establish an audit committee. 
The Board has established an Audit and Risk Committee. 

Recommendation 4.2: Structure the audit committee so that it consists of only non-executive directors; a 
majority of independent directors; an independent chairperson, who is not chairperson of the board; at 
least three members. 
The Company has appointed an Audit and Risk Committee (“Committee”), responsible for reporting to the full 
Board on issues relating to the Company’s financial information and a regular review of the Company’s risk 
environment. 

The Committee is made up of two members, both independent Directors.  The Chairman of the Committee is an 
independent director.  The size of the Committee, although not in compliance with the ASX Principles, is 
considered appropriate for the size of the Company. The Committee will meet at least three times per year. 

Recommendation 4.3: The audit committee should have a formal charter. 
The Committee operates according to a formal charter. 

Recommendation 4.4: Provide the information indicated in the Guide to reporting on Principle 4. 
The qualifications of the Committee members are set out in the Directors’ Report together with their attendance 
at Committee meetings.   

The Committee charter, which includes information regarding the external auditor’s engagement, is included in 
the Uscom Corporate Governance Documentation on the Company website. 

Principle 5: Make timely and balanced disclosure 
Recommendation 5.1: Establish written policies designed to ensure compliance with ASX Listing Rule 
disclosure requirements and to ensure accountability at a senior executive level for that compliance and 
disclose those policies or a summary of those policies. 
The Company has produced and adopted a disclosure policy, which has been communicated to all Directors, 
managers and employees. 

The Board, Company Secretary and senior executives are aware of the ASX Listing Rules and Corporations Act 
disclosure requirements, and take steps to actively monitor and ensure ongoing compliance.   

The Executive Chairman in consultation with the Company Secretary, continually monitors developments in the 
Company and its business and reports any developments immediately to the Board for consideration.  

Recommendation 5.2: Provide information indicated in the Guide to reporting on Principle 5. 
Refer to the Uscom Corporate Governance documentation on the Company website. 

Principle 6: Respect the rights of shareholders 
Recommendation 6.1: Design a communications policy for promoting effective communication with 
shareholders and encouraging their participation at general meetings and disclose their policy or a 
summary of that policy. 
Uscom Ltd is committed to keeping shareholders fully informed of significant developments and activities at the 
Company. 

The Company’s primary communications tool is its website, and all announcements are posted on the site, 
immediately after they are released to the ASX through the appropriate electronic publication procedure. 

Where information may be provided to market analysts or the media which is materially incremental to the 
announcements already published, this information would be treated as an announcement and published 
accordingly. 

All announcements, dating back to May 2001, remain available on the website. 

In addition, the website provides an “Investors” section, where more detailed information is available, including 
access to all of the Company’s financial statements and the delayed share trading data produced by ASX. 

Shareholders are encouraged to actively communicate with the Company through contact details provided on 
the website. 

Uscom Limited - Annual Report 2012 - 7 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CORPORATE GOVERNANCE STATEMENT continued 

The Company also encourages shareholders to participate in the annual general meeting. 

Ample notice of this meeting will be provided. All documents and presentations delivered to the annual general 
meeting will be posted immediately on the Company website. 

Recommendation 6.2: Provide the information indicated in the Guide to reporting on Principle 6. 
Refer to the Uscom Corporate Governance documentation on the Company website. 

Principle 7: Recognise and manage risk 
Recommendation 7.1: Establish policies for the oversight and management of material business risks and 
disclose a summary of those policies. 
The Company has appointed an Audit and Risk Committee, which is charged with oversight of the Company’s risk 
profile. The Committee assesses the adequacy of the Company’s control and risk environment, including 
accounting, financial and operating controls and the appropriateness of its accounting policies and practices. The 
committee manages a dynamic checklist of potential risk components and reviews each component during the 
course of a year. 

Recommendation 7.2: Require management to design and implement the risk management and internal 
control system to manage the Company’s material business risks and report to it on whether those risks are 
being managed effectively. The board should disclose that management has reported to it as to the 
effectiveness of the Company’s management of its material business risks. 
The Board has required Management to design and implement the risk management and internal control system 
to manage the company's material business risks and report to it on whether those risks are being managed 
effectively. Management has reported to the Board as to the effectiveness of the Company’s management of its 
material business risk. 

Recommendation 7.3: Disclose whether it has received assurance from the Chief Executive Officer (or 
equivalent) and Chief Financial Officer (or equivalent) that the declaration provided in accordance with 
section 295A of the Corporations Act is founded on a sound system of risk management and internal 
control and that the system is operating effectively in all material respects in relation to financial reporting 
risks. 
The Board has received assurance from the Chief Executive Officer and the General Manager that the declaration 
provided  in  accordance  with  section  295A  of  the  Corporations  Act  2001  is  founded  on  a  sound  system  of  risk 
management and internal control and that the system is operating effectively in all material respects in relation to 
financial reporting risks. 

Recommendation 7.4: Provide the information indicated in the Guide to reporting on Principle 7. 
The Board has received the report from management under recommendation 7.2 and the assurance from the 
Chief Executive Officer and the General Manager under recommendation 7.3.  

Refer to the Audit and Risk Committee Charter included in Uscom Corporate Governance on the Company 
website for further information regarding the Company’s policies on risk oversight and management of material 
business risks. 

Principle 8: Remunerate fairly and responsibly 
Recommendation 8.1: Establish a Remuneration Committee. 
Given the relatively small size of the Uscom board, the Company does not currently see the need for a separate 
remuneration committee. 

Uscom Ltd has adopted a remuneration policy based on performance and contribution. 

Is chaired by an independent chair 

Recommendation 8.2: The remuneration committee should be structured so that it: 
•  Consists of a majority of independent directors 
• 
•  Has at least three members. 
As set out above, given the relatively small size of the Uscom board, the Company does not currently see the 
need for a separate remuneration committee. 

Uscom Limited - Annual Report 2012 - 8 

 
 
 
 
 
 
 
 
 
 
 
 
 
CORPORATE GOVERNANCE STATEMENT continued 

Recommendation 8.3: Clearly distinguish the structure of non-executive directors’ remuneration from that 
of executive directors and senior executives. 
Information regarding the remuneration of non-executive Directors, executive Directors and Senior Executives is 
provided in the Company’s Remuneration Report from pages 13 to 17. 

Recommendation  8.4:  Companies  should  provide  the  information  indicated  in  the  guide  to  reporting  on 
Principle 8. 
There  are  no  schemes  for  retirement  benefits,  other  than  superannuation,  for  non-executive  directors.  Non-
executive directors do not receive options or bonus payments.  

The Company’s departure from Recommendations 8.1 and 8.2 are explained above.  

Uscom Limited - Annual Report 2012 - 9 

 
 
 
 
DIRECTORS’ REPORT 

The Directors present their report on Uscom Ltd and its Controlled Entity for the financial year ended 30 June 
2012. 

Directors 
The following persons were Directors of Uscom Ltd during the whole of the financial year and up to the date of 
this report, unless otherwise stated. 

Mr R A Phillips 
Ms S Jack 
Mr C Bernecker 
Mr P Kiely 
Mr B Rathie 
Mr J Bonitz 

Executive Director - Chairman 
Non-Executive Director (Appointed on 25th November 2011) 
Non-Executive Director (Appointed on 25th November 2011) 
Executive Chairman (Ceased on 22nd November 2011) 
Non-Executive Director (Resigned on 30th August 2011) 
Non-Executive Director (Ceased on 22nd November 2011) 

Directors’ qualifications and experience 
Mr Rob Phillips 
Rob Phillips is the founder of Uscom Ltd, the Chief Executive Officer, Executive Director and Chief Scientist of the 
Company. Rob has 9 years experience as Executive Chairman of the Company, having taken the Company to IPO 
in 2003, and has over 20 years in executive corporate management. The Company received the Frost and Sullivan 
Global Entropolis Award for the Emerging Medical Device Company of the Year in 2007. He has a Master of 
Philosophy in Medicine from The University of Queensland and is currently completing his PhD. He is an 
Australian Post Graduate Award recipient and was a finalist in the Time-CNN World Health and Medicine 
Technology Awards in 2004. Rob has pioneered novel clinical approaches to cardiovascular assessment having 
authored over 30 patents and patent applications and is an internationally recognised teacher and examiner in 
the field of echocardiography. 

Ms Sheena Jack 
Ms Sheena Jack was appointed Non-Executive Director of Uscom Ltd on 25th November 2011 and is also the 
Chairman of the Audit and Risk Committee.  
Sheena is currently the Chief Financial Officer of HCF and has 26 years experience as a finance professional and 
corporate executive. She has had experience across a range of corporate organisations including ASX listed 
companies, government and not for profit in both mature and start-up businesses. Sheena has significant 
experience in mergers and acquisitions, business integration, strategy development and implementation, capital 
markets and organisational transformation. She is a Director of Moneytime Health Pty Ltd and Treytell Pty Ltd.   
Sheena is a Chartered Accountant and a graduate member of the Australian Institute of Company Directors. 

Mr Christian Bernecker 
Mr Christian Bernecker was appointed Non-Executive Director of Uscom Ltd on 25th November 2011 and is also a 
member of the Audit & Risk Committee.  
Christian is Managing Director of Nightingale Partners Pty Limited, an active investment company which provides 
expansion capital to small cap companies.  He is currently a Non-Executive Director of LongReach Group Limited, 
DSQ Holdings Limited, Australis Music Group Pty Limited, Creditorwatch Pty Limited, Mayfield Industries Pty 
Limited, Stream Group Holdings Pty Limited and a number of other private companies. 
Christian is a member of the Institute of Chartered Accountants in Australia and holds a Bachelor of Commerce 
from Ballarat University. 

Mr Phil Kiely (Ceased on 22nd November 2011) 
Mr Kiely was the Executive Chairman for Uscom Ltd until 22nd November 2011. Mr Kiely holds a Bachelor of 
Commerce/Law degree from the University of NSW. 
Phil Kiely has over 25 years in the ICT sector working in leading global companies most recently establishing an 
investment company, Matrix Capital Corporation, which has developed and commercialised innovative product & 
services organisations. Prior to Matrix Phil spent seven years at Oracle Corporation, the world’s largest database 
company. His last role at Oracle was as Vice President Oracle Online, Asia Pacific. Prior to joining Oracle, Phil was 
one of the pioneers of IT outsourcing in Australia. He held positions as General Manager, Continuum Australia 
later acquired by CSC and General Manager, Computations.  

Mr Bruce Rathie (Resigned on 30th August 2011) 
Mr Rathie was a Non-Executive Director of Uscom Ltd until 30th August 2011. He holds degrees in law, commerce 
and business and has considerable experience as a lawyer having practiced as a solicitor and partner in a major 
Brisbane based legal firm and then as Senior in-house Counsel to Bell Resources Limited from 1980 to 1985 in 
aggregate. He studied for his MBA in Geneva and then went into investment banking in 1986 which subsequently 
took him to New York for over 2 years returning to Sydney in 1990. He spent the 90's in investment banking in

Uscom Limited - Annual Report 2012 - 10 

 
 
 
 
 
 
 
 
 
DIRECTORS’ REPORT continued 

Sydney, the last 5 years as a Director of Investment Banking at Salomon Brothers/ Salomon Smith Barney where 
he was responsible for the firm's activities/ roles in the industrial sector and the Federal Government's 
privatisation of Qantas, Commonwealth Bank (CBA3) and Telstra (T1). Mr Rathie currently holds board positions 
with a number of Australian companies. 

During the past three years Mr Rathie held senior positions of the following listed companies: 

•  DataDot Technology Limited 

Non-Executive & Chairman 

•  Anteo Diagnostics Limited 
•  Calzada Limited 
•  Mungana Goldmines Limited 
Mr Rathie was a member of the Audit and Risk Committee until 30th August 2011. 

Chairman and Non-Executive Director 
Non- Executive Director 
Non- Executive Director 

December 2006 – January 2009 
& October 2009 - present 
July 2006 – August 2009 
April 2010 - present 
October 2010 - present 

Mr Jochen Bonitz (Ceased on 22nd November 2011) 
Mr Bonitz was a Non-Executive Director of Uscom Ltd until 22nd November 2011.  He holds a Bachelor of Science 
degree from the University of NSW and a MBA from the Australian Graduate School of Management. 
Mr Bonitz was a former Director at KPMG Corporate Finance with over 20 years experience in the technology 
sector spanning a career in programming, consulting and Mergers & Acquisitions advisory. 
Having focused initially in the technical field and consulting at Logica and IBM, Mr Bonitz started and developed 
a communication company which he merged into Pacnet where he was then the CEO for the Australian 
subsidiary. He later worked with the Commonwealth Bank and at KPMG as a corporate M&A adviser with a 
specific focus on the ICT and telecoms sectors. Most recently he has been on the direction panel for the Federal 
Government’s National Broadband Network (NBN). 
Mr Bonitz was a member of the Audit and Risk Committee until 22nd November 2011. 

Company Secretary’s qualifications and experience 
Mr Tom Rowe 
Mr Rowe was appointed the Company Secretary of Uscom Ltd on 7th December 2011. He is a Corporate and 
Commercial Lawyer with a specialty in listed company secretarial practice. Mr Rowe holds a BA LLB (Hons) from 
the University of Adelaide and is an Associate of the Chartered Institute of Secretaries. He is the current Principal 
of Company Matters, a specialist provider of legal, governance and company secretarial services. Previously, he 
held the position of Legal Counsel and Company Secretary at CSR Ltd.   

Meetings of Directors 
Directors 

Board of Directors 

Audit and Risk Committee 

R A Phillips 
S Jack ** 
C Bernecker ** 
P Kiely * 
B Rathie *** 
J Bontiz * 

Meetings held while 
a Director 
13 
8 
8 
4 
2 
4 

No. of meetings 
attended 
12 
8 
6 
4 
2 
4 

Meetings held while a 
Director 
- 
1 
1 
- 
1 
1 

No. of meetings 
attended 
- 
1 
1 
- 
1 
1 

* Ceased on 22nd November 2011 
** Appointed on 25th November 2011 
*** Resigned on 30th August 2011 

Principal activities 
Uscom Ltd is engaged in the development, design, manufacture and marketing of non-invasive cardiac 
monitoring devices.  Uscom Ltd owns a portfolio of intellectual property relating to the technology and 
techniques associated with these devices and manages a worldwide network of distribution partners for the sale 
of its equipment to hospitals and other medical care locations. Uscom Ltd owns 100% of Uscom, Inc. a company 
engaged in the sale and promotion of USCOM devices primarily in the United States. 

Operating result 
The loss of the Consolidated Entity after providing for income tax amounted to $1,824,547 (2011: $2,685,913) 

Dividends 
No dividends were declared or recommended for the financial year ended 30 June 2012. 

Uscom Limited - Annual Report 2012 - 11 

 
 
 
 
 
 
 
 
 
 
 
DIRECTORS’ REPORT continued 

Significant changes in state of affairs 
There were no significant changes in state of affairs during the financial year apart from the change of Board of 
Directors and Management following the AGM in November 2011. 

Operating and financial review 
The operating and financial review is stated on pages 2 to 3 of this report. 

Events after the reporting date 
Apart from the items disclosed in note 29 to the financial statements, no other matters or circumstances have 
arisen since the end of the financial year to the date of this report, that has significantly affected or may 
significantly affect the activities of the Consolidated Entity, the results of those activities or the state of affairs of 
the Consolidated Entity in the ensuing or any subsequent financial year. 

Future developments 
Other than the business activities described in the annual report and, in particular, those matters discussed in the 
Review of Operations, the Board is not aware of any likely developments in the foreseeable future which may 
materially impact on the financial outlook of the Consolidated Entity. 

Environmental issues 
The Consolidated Entity’s operations are not subject to significant environmental regulation under the law of the 
Commonwealth and State. 

Indemnifying officers 
The Consolidated Entity has paid premiums to insure all Directors and Executives against liabilities for costs and 
expenses incurred by them in defending any legal proceedings arising out of their conduct while acting in the 
capacity of Director of the Company, other than conduct involving a wilful breach of duty in relation to the 
Company. 

Proceedings on behalf of the Consolidated Entity 
No person has applied to the Court under section 237 of the Corporations Act 2001 for leave to bring 
proceedings on behalf of the Consolidated Entity, or to intervene in any proceedings to which the Consolidated 
Entity is a party, for the purpose of taking responsibility on behalf of the Consolidated Entity for all or part of 
those proceedings. 

No proceedings have been brought or intervened in on behalf of the Consolidated Entity with leave of the Court 
under section 237 of the Corporations Act 2001. 

Non-audit services 
The Consolidated Entity may decide to employ the auditor on assignments additional to their audit duties where 
the auditor’s expertise and experience with the Consolidated Entity are important. 

During the year, $2,956 was paid to PKF California for tax consulting services provided to the Consolidated Entity. 
The Directors are of the opinion that the provision of non-audit services as disclosed in note 26 in the financial 
report does not compromise the external auditor’s independence as outlined in the Corporations Act 2001 for 
the following reasons: 

•  All non-audit services have been reviewed and approved to ensure that they do not impact the integrity 

and objectivity of the auditor, and 

•  None of the services undermine the general principles relating to auditor independence as set out in the 

Code of Conduct APES110 Code of Ethics of Professional Accountants issued by the Accounting 
Professional and Ethical Standards Board, including reviewing or auditing the auditor’s own work, acting 
in management decision making capacity for the Company, acting as advocate for the Company or 
jointly sharing economic risks and rewards. 

Refer to note 26 of the financial statements on page 42 for details of auditors’ remuneration.  

The auditor’s independence declaration under section 307C of the Corporation Act is set out on page 18 and 
forms part of the Directors’ Report. 

Uscom Limited - Annual Report 2012 - 12 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIRECTORS’ REPORT continued 

Remuneration report 
This remuneration report has been prepared by the Directors of Uscom Ltd to comply with the Corporations Act 
2001 and the key management personnel (KMP) disclosures required under Australian Accounting Standards 
AASB 124 – Related Party Disclosures. 

Key management personnel 
The following were key management personnel of the Entity at the start of the financial year to the date of this 
report unless otherwise stated: 
Non-Executive Directors 
Sheena Jack, Non-Executive Director  (commenced on 25th November 2011) 
Christian Bernecker, Non-Executive Director  (commenced on 25th November 2011) 
Bruce Rathie, Non-Executive Director  (ceased on 30th August 2011) 
Jochen Bonitz, Non-Executive Director  (ceased on 22nd November 2011) 
Executive Directors 
Rob Phillips, Executive Director, Chairman, Chief Executive Officer   
Phil Kiely, Executive Chairman  (ceased on 22nd November 2011) 
Senior Executives 
Tom Rowe, Company Secretary  (commenced on 7th December 2011) 
Nick Schicht, General Manager  
Daniel Fah, Chief Financial Officer, Company Secretary  (ceased on 30th November 2011) 
Deb Johnson, VP Sales and Marketing  (ceased on 8th June 2012) 
Joe Trygar, Chief Executive Officer  (from 16th September 2011 to 2nd December 2011) 

In the Directors’ opinion, there are no other Executives of the Entity. 

Remuneration policies 
The Board is responsible for reviewing the remuneration policies and practices of the Consolidated Entity, 
including the compensation arrangements of Executive Directors, Non-Executive Directors and Senior Executives.  

The Consolidated Entity has adopted remuneration policies based on performance and contribution for 
determining the nature and amount of emoluments of Board Member and Senior Executives. The objective of 
these policies is to: 

•  Make Uscom Ltd and its Controlled Entity an employer of choice 
•  Attract and retain the highest calibre personnel 
•  Encourage a culture of reward for effort and contribution 
•  Set incentives that reward short and medium term performance for the Consolidated Entity 
•  Encourage professional and personal development 

In the case of Senior Executives, a recommendation for compensation review will be made by the Chairman to 
the Board, which will conduct a performance review. 

Non-Executive Directors 
The Board determines the Non-Executive Director remuneration by independent market data for comparative 
Companies.  

As at the date of this report the maximum aggregate remuneration payable out of the funds of the Entity to Non-
Executive Directors of the Consolidated Entity for their services as Directors including their service on a 
committee of Directors is $165,000 per annum. 

Non-Executive Directors do not receive any performance related remuneration, therefore they do not receive 
bonuses or non-cash benefits. 

Non-Executive Directors’ retirement payments are limited to compulsory employer superannuation. 

Executive Directors and Senior Executives remuneration 
The Consolidated Entity’s remuneration policy directs that the remuneration package appropriately reflects the 
Executives’ duties and responsibilities and that remuneration levels attract and retain high calibre Executives with 
the skills necessary to successfully manage the Consolidated Entity’s operations and achieve its strategic and 
financial objectives. 

Uscom Limited - Annual Report 2012 - 13 

 
 
 
 
 
 
 
 
 
 
 
DIRECTORS’ REPORT continued 

The total remuneration packages of Executive Directors and Senior Executives are on a salary basis. In addition to 
base salary, the Company has a policy of rewarding extraordinary contribution to the growth of the Company with 
the grant of an annual discretionary cash bonus and options under the Consolidated Entity’s Employee Share 
Option Plan. 

Executives are also entitled to be paid for their reasonable travel, accommodation and other expenses incurred in 
consequence in the execution of duties. 

Other than the Uscom Ltd Employee Share Option Plan, the Consolidated Entity does not provide any other non-
cash benefits in lieu of base salary to Executives. 

Remuneration packages for Executive Directors and Senior Executives generally consist of three components: 
•  Fixed remuneration which is made up of cash salary, salary sacrifice components and superannuation 
•  Short term incentives 
•  Long term incentives which include issuing options pursuant to the Uscom Ltd Employee Share Option Plan. 

Fixed remuneration 
Senior Executives who possess a high level of skill and experience are offered a competitive base salary. The 
performance of each Executive will be reviewed annually. Following the review, the Consolidated Entity may in its 
sole discretion increase the salary based on that Executive’s performance, productivity and such other matters as 
the Board considers relevant. Superannuation contribution by the Consolidated Entity is limited to the statutory 
level at 9% of wages and salaries. 

Short-term incentives 
The remuneration of Uscom Ltd Senior Executives does not include any short-term incentive bonuses as part of 
their employment conditions. The Board may however approve discretionary bonuses to Executives in relation to 
certain milestones being achieved.  

Long-term incentives 
The Consolidated Entity has adopted a Share Option Plan for the benefit of Executive Directors, full-time and 
part-time staff members employed by the Consolidated Entity. 

In accordance with the employee option plan, options issued under the employee option plan, have an exercise 
price based on 85% of the average ASX closing price for the 5 days prior to offer/acceptance of the options. Each 
option is issued for a period of 4 years, which vest 25% in tranches throughout the period. 

An Executive Share Option Plan has also been developed for approved participants. 

The Board, at its discretion, may approve the issue of options under the Employee Share Option Plan and the 
Executive Share Option Plan to Senior Executives. The vesting of options issued may be conditional upon the 
achievement of performance hurdles determined by the Board from time to time. The Board may propose the 
issue of options to Directors, however this will be subject to shareholder approval at the Annual General Meeting. 

Independent data from applicable sources may be requested by the Board to assess whether the performance 
hurdles have been met. 

During the year, 400,000 options were issued to employees under the Employee Share Option Plan at an exercise 
price of 5.95 cents per option and 400,000 options were issued to executives under the Executive Share Option 
Plan at an exercise price of 5.95 cents per option. 

Service agreements 
The Consolidated Entity has entered into a service agreement with the Chairman that  
•  Outlines the components of remuneration payable; and  
•  Specifies term and termination conditions. 

Details of the service agreement are as follows: 

Term 
The Executive Employment Agreements are for a term of 3 years. The term of employment may be extended by 
the Consolidated Entity after the expiration of the initial 3 year term. 

Each Executive may not, during the term of the employment agreement, perform work for any other person, 
corporation or business without the prior written consent of the Consolidated Entity. 

Uscom Limited - Annual Report 2012 - 14 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIRECTORS’ REPORT continued 

Due to the small number of Executives the remuneration committee comprises the Board of Directors which is 
made up of two Non-Executive Directors. Reference is made to external market information in order to retain the 
most suitable Executives for meeting the entity’s goals. Executive Directors are excluded from discussions on 
their remuneration. The remuneration of key Executives are not linked with the Consolidated Entity’s performance 
as the focus is on retention of key Executives to ensure growth and traction in what is a new market. The Board of 
Directors will consider linking executive remuneration to Consolidated Entity’s performance once the 
Consolidated Entity has sufficient market traction. 

Termination 
Despite anything to the contrary in the agreement, the Consolidated Entity or the Executive may terminate the 
employment at any time by giving the other party 3 months’ notice in writing. 

If either the Consolidated Entity or the Executive gives notice of termination, the Consolidated Entity may, at its 
discretion, choose to terminate the Executive’s employment immediately or at any time during the notice period 
and pay the Executive an amount equal to the salary due to them for the residual period of notice at the time of 
termination. 

Where the Executive gives less than 3 months written notice, the Consolidated Entity may withhold from the 
Executive’s final payment an amount equal to the shortfall in the notice period. 

The employment of each Executive may be terminated immediately without notice or payment in lieu in the event 
of any serious or persistent breach of the agreement, any serious misconduct or wilful neglect of duties, in the 
event of bankruptcy or any arrangement or compensation being made with creditors, on conviction of a criminal 
offence, permanent incapacity of the Executive or a consistent failure to carry out duties in a manner satisfactory 
to the Consolidated Entity.  

Directors and Executives remuneration 
Remuneration includes salaries, benefits and superannuation contributions in respect of the financial year 2012. 

Non-Executive Director 
S Jack (from 25 Nov 2011) 
C Bernecker (from 25 Nov 2011) 
B Rathie (to 30 Aug 2011) 
J Bonitz (to 22 Nov 2011) 
Executive Director 
R Phillips 
P Kiely (to 22 Nov 2011) 
Senior Executive 
T Rowe (from 7 Dec 2011) 
N Schicht 
D Fah (to 30 Nov 2011) 
D Johnson (to 8 Jun 2012) 
J Trygar (from 15 Jul to 2 Dec 2011) 

Equity 

Total 
remuneration 

Short term benefits 

Directors’ 
Base Fee 
$ 

- 
- 
5,833 
- 

Base salary 

$ 

- 
- 
- 
- 

Other 
payments 
$ 

- 
- 
- 
- 

Post employment 
benefits 

Superannuation 

$ 

- 
- 
525 
- 

171,090 
- 

- 
60,000(2) 

46,281(1) 
- 

Share-based 
payment 
$ 

% of total 

- 
- 
- 
- 

- 
- 

- 
- 
- 
- 

- 
- 

- 
- 

- 
- 
- 
- 
- 

- 
166,000 
- 
139,640 
58,145 

1,965(3) 
- 
26,360(4) 
14,323 
- 

- 
14,940 
- 
- 
- 

61,746 

- 
642 
- 
564 
- 

1,206 

- 
0.4% 
- 
0.4% 
- 

- 

$ 

- 
- 
6,358 
- 

217,371 
60,000 

1,965 
181,582 
26,360 
154,527 
58,145 

706,308 

Total 

5,833 

534,875 

102,648 

(1) 
(2) 
(3) 
(4) 

$28,333 of Directors’ salary was sacrificed to post employment benefit during FY2012 
Payments were made to Ecrucis Pty Ltd for the services provided by Mr Kiely. 
Payments were made to Company Matters Pty Ltd for the services provided by Mr Rowe.  
Payments were made to CFO Strategic Chartered Accountants for the services provided by Mr Fah. 

Uscom Limited - Annual Report 2012 - 15 

 
 
 
 
 
 
 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIRECTORS’ REPORT continued 

Directors and Executives remuneration 
Remuneration includes salaries, benefits and superannuation contributions in respect of the financial year 2011. 

Non-Executive Director 
R Zwolenski (to 22 Dec 2010) 
B Rathie   
J Bonitz (from 4 Jan 2011) 
Executive Director 
R Phillips 
P Kiely (from 22 Dec 2010) 
Senior Executive 
D Fah  
N Schicht 
A Hughes-Jones (to 10 Dec 2010) 
D Johnson 

Short term benefits 

Directors’ 
Base Fee 
$ 

17,500 
35,000 
- 

Base salary 

$ 

- 
- 
- 

Other 
payments 
$ 

- 
- 
- 

Post employment 
benefits 

Superannuation 

$ 

1,575 
3,150 
- 

Equity 

Total 
remuneration 

Share-based 
payment 
$ 

% of total 

- 
- 
29,440 

- 
- 
100.0% 

$ 

19,075 
38,150 
29,440 

- 
- 

- 
- 
- 
- 

155,000 
- 

- 
108,000(1) 

13,950 
- 

- 
294,400 

- 
73.2% 

168,950 
402,400 

- 
157,900 
43,080 
143,174 

65,994(2) 
- 
- 
13,412 

- 
14,211 
23,101 
- 

55,987 

1,297 
2,594 
- 
- 

1.9% 
1.5% 
- 
- 

67,291 
174,705 
66,181 
156,586 

327,731 

- 

1,122,778 

Total 

52,500 

499,154 

187,406 

(1) 
(2) 

Payments were made to Ecrucis Pty Ltd for the services provided by Mr Kiely. 
Payments were made to CFO Strategic Chartered Accountants for the services provided by Mr Fah. 

Employee Share Option Plan 
The Consolidated Entity has adopted an Employee Share Option Plan for the benefit of Executive Directors and 
full-time or part-time staff members employed by the Consolidated Entity. At the date of this Report the following 
options had been issued pursuant to the Employee Share Option Plan. Each option was issued for a period of 4 
years and vest in tranches of 25% after 9 months, 12 months, 24 months and 36 months. 

Exercise price is based on 85% of the average ASX closing price for the 5 days prior to offer/acceptance of the 
options, in accordance with the Employee Share Option Plan. 

An Executive Share Option Plan has also been developed to provide approved participants further incentive in 
their performance for the Consolidated Entity and an opportunity to acquire an ownership interest in the 
Consolidated Entity. 

Number of options over ordinary shares held by Directors and Senior Executives 

Balance 

Granted 

Exercised 

Lapsed / 
Transferred 
out 

Balance 

Total vested 

Non-Executive Director 
S Jack (from 25 Nov 2011) 
C Bernecker (from 25 Nov 2011) 
B Rathie (to 30 Aug 2011) 
J Bonitz (to 22 Nov 2011) 
Executive Director 
R Phillips 
P Kiely (to 22 Nov 2011) 
Senior Executive 
T Rowe (from 7 Dec 2011) 
N Schicht 
D Fah (to 30 Nov 2011) 
D Johnson (to 8 Jun 2012) 
J Trygar (to 2 Dec 2011) 

Total 

1 July 2011 

No. 

- 
- 
- 
400,000  

- 
4,000,000 

- 
100,000  
50,000 
- 
- 

4,550,000 

During 
FY2012 
No.

During
 FY2012 
No.

During FY2012 

30 June 2012 

No.

No. 

& exercisable 
30 June 2012 
No.

- 
- 
- 
- 

- 
- 

- 
300,000 
- 
150,000 
- 

450,000 

- 
- 
- 
- 

- 
- 

- 
- 
- 
- 
- 

- 

- 
- 
- 
(400,000) 

- 
(4,000,000) 

- 
- 
(50,000) 
(150,000) 
- 

(4,600,000) 

- 
- 
- 
- 

- 
- 

- 
400,000 
- 
- 
- 

400,000 

- 
- 
- 
- 

- 
- 

- 
100,000 
- 
- 
- 

100,000 

Uscom Limited - Annual Report 2012 - 16 

 
 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
  
  
  
  
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
DIREC

CTORS’

’ REPOR

RT conti

nued 

Details 

of options

s outstandin

ng as at en

nd of year

Holders N

No. 

Grant d

date 

Exerc
at 30

cisable
0 June 
2012 
%
100% 
100% 

e 
 Expiry date

20 
17 

November 20
December 20

12
13

30 June 2
Outstand
Op

2012 
ding 
ption 
No. 
0,000 
0,000 

260
2,000

cise 
Exerc
rice 
Pr

$
0
0.29 
375 
0.3

Issue
date fa
valu

ed 
air 
ue 
$
19 
12 

0.1
0.1

0 November 2
20
7 December 2
17

2008 
2008 

29 March 2

2012 

0% 

29 March 20

16

1,300

0,000 

0.05

595 

0.0

06 

3,560

0,000 

yees) 
7 (Employ
or) 
1 (Investo
oyees & 
10 (Emplo
e) 
Executive

Total 

Further details 

of the options are disc

closed in note 19 of the

e financial statements.

Numbe

er of shares

s held by D

irectors an
Balance 
July 2011 
No. 

xecutives (
nd Senior E
Op
s 
Received as
Exer
Remuneration
R
No.

indirect int
(including i
Net change 
N
ptions 
Other* 
cised 
No. 
No. 

erest) 

ce 
Balanc
12 
30 June 20
No. 
N

1 J

cutive Direct
m 25 Nov 2011) 
ker (from 25 Nov 2
(to 30 Aug 2011) 
to 22 Nov 2011) 
e Director 

Non-Exe
S Jack (from
C Bernec
B Rathie (
J Bonitz (t
Executive
R Phillips 
P Kiely (to 
22 Nov 2011) 
Senior Ex
xecutive 
rom 7 Dec 2011) 
T Rowe (fr
t 
N Schicht
30 Nov 2011) 
D Fah (to 3
on (to 8 Jun 2012) 
D Johnso
to 2 Dec 2011) 
J Trygar (t

or 

011) 

- 
- 
93,809 
- 

6,996,733 
16
333,333 

- 
18,200 
5,000 
5,100 
- 

Total 

17

,452,175 

-
- 
-
- 
-
- 
- 
-

-
- 
- 
-

- 
-
-
- 
-
- 
-
- 
- 
-

- 
-

- 
- 
- 
- 

- 
- 

- 
- 
- 
- 
- 

- 

80,000 
- 
(93,809) 
- 

80,000

0(1) 
- 
-(2) 
- 

- 
(333,333) 

16,996,733

3(3) 
-(4) 

- 
- 
(5,000) 
(5,100) 
- 

18,200

- 
0(5) 
-(6) 
-(7) 
- 

(357,242) 

17,094,93

33 

*Net change ot
(1) All these ord

ther refers to share pur
dinary shares are held b

rchased or sold during
by family associate. 

 the financial year, or c

cessation of categorisa

ation as a Director or Se

enior Executive. 

(2) Bruce Rathie

e ceased to be key man

nagement personnel o

on 30 August 2011. 

(3) 382,924 of th

hese ordinary shares ar

re held by Australian C

Cardiac Sonography Pty

y Ltd as trustee for the

e Phillips Superannuatio

on. 

(4) Phil Kiely cea

ased to be key manag

ement personnel on 22

2 November 2011. 

(5) 10,000 of the

ese ordinary shares are

e held by family associa

ate. 

(6) Daniel Fah c

ceased to be key mana

agement personnel on 

30 November 2011. 

(7) Deb Johnso

n ceased to be key ma

anagement personnel o

on 8 June 2012. 

This Direc

ctor’s report is

s signed in acc

cordance with

h a resolution o

of the Board o

of Directors. 

Rob Philli

ips 

Sheena J

ack 

Executive

e Director - Ch

hairman 

Non-Exe

cutive Directo

or 

Sydney, 3

30 August 201

2 

Uscom Limited 

- Annual Repor

rt 2012 - 17 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
  
 
 
AUDITOR’S INDEPENDENCE DECLARATION 

Tel: +61 2 9251 4100 
Fax: +61 2 9240 9821 
www.bdo.com.au 

Level 10, 1 Margaret St  
Sydney NSW 2000 
Australia 

DECLARATION OF INDEPENDENCE BY TIM SYDENHAM TO THE DIRECTORS OF USCOM LIMITED 

As lead auditor of Uscom Limited for the year ended 30 June 2012, I declare that, to the best of 
my knowledge and belief, there have been no contraventions of: 

• 

• 

the auditor independence requirements of the Corporations Act 2001 in relation to the 
audit; and 
any applicable code of professional conduct in relation to the audit. 

This declaration is in respect of Uscom Limited and the entities it controlled during the year.  

Tim Sydenham 

Partner  

BDO East Coast Partnership 

Sydney, 30 August 2012 

BDO East Coast Partnership  ABN 83 236 985 726 is a member of a national association of independent entities which are all members of BDO (Australia) Ltd ABN 77 050 
110 275, an Australian company limited by guarantee. BDO East Coast Partnership and BDO (Australia) Ltd are members of BDO International Ltd, a UK company limited 
by guarantee, and form part of the international BDO network of independent member firms. Liability limited by a scheme approved under Professional Standards 
Legislation (other than for the acts or omissions of financial services licensees) in each State or Territory other than Tasmania. 

Uscom Limited - Annual Report 2012 - 18 

 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INCOME STATEMENT 
For the financial year ended 30 June 2012 

Continuing operations 

Revenue 
Raw materials and consumables used 
Expenses from continuing activities 

Loss before income tax credit 

Income tax credit 

Loss after income tax credit 

Earnings per share (EPS) 
Basic earnings per share (cents per share) 
Diluted earnings per share (cents per share) 

Consolidated 

2012 

$ 

2011 

$ 

Note 

3 

4 

5 

6 

7 

7 

864,099 
(212,924) 
(2,881,975) 

880,873 
(251,541) 
(3,660,141) 

(2,230,800) 

(3,030,809) 

406,253 

344,896 

(1,824,547) 

(2,685,913) 

(3.5) 
(3.5) 

(5.8) 
(5.8) 

This Income Statement is to be read in conjunction with the attached notes. 

Uscom Limited - Annual Report 2012 - 19 

 
  
 
 
  
  
 
  
  
  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STATEMENT OF COMPREHENSIVE INCOME 
For the financial year ended 30 June 2012 

Loss for the year 

Other comprehensive income 

Foreign currency translation difference for foreign operations 

Other comprehensive income for the year 

Consolidated 

2012 

$ 

2011 

$ 

(1,824,547) 

(2,685,913) 

2,830 

2,830 

8,143 

8,143 

Total comprehensive loss for the year 

(1,821,717) 

(2,677,770) 

Attributable to: 

Owners of the Company 

(1,821,717) 

(2,677,770) 

Total comprehensive loss for the year 

(1,821,717) 

(2,677,770) 

This Statement of Comprehensive Income is to be read in conjunction with the attached notes. 

Uscom Limited - Annual Report 2012 - 20 

 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STATEMENT OF FINANCIAL POSITION 
As at 30 June 2012 

Current assets 
Cash and cash equivalents 
Trade and other receivables 
Inventories 
Tax asset 
Other assets 

Total current assets 

Non-current assets 
Plant and equipment 
Intangible assets 

Total non-current assets 

Total assets 

Current liabilities 
Trade and other payables 
Short term provisions 

Total current liabilities 

Non-current liabilities 
Long term provisions 

Total non-current liabilities 

Total liabilities 

Net assets 

Equity 
Issued capital 
Unissued capital 
Options reserve 
Accumulated losses 
Translation reserve 

Total equity 

Consolidated 

2012 

$ 

2011 

$ 

Note 

8 

9 

10 

11 

14 

12 

13 

15 

16 

16 

544,463 
140,936 
191,030 
406,253 
41,946 

1,324,628 

2,125,156 
163,991 
213,882 
344,896 
72,589 

2,920,514 

68,258 
435,472 

503,730 

93,289 
510,487 

603,776 

1,828,358 

3,524,290 

108,357 
122,983 

231,340 

148,273 
142,269 

290,542 

126,952 

126,952 

98,143 

98,143 

358,292 

388,685 

1,470,066 

3,135,605 

17 

18 

19 

6 

20 

21,376,920 
150,000 
1,379,673 
(21,510,754) 
74,227 

21,376,920 
- 
1,373,495 
(19,686,207) 
71,397 

1,470,066 

3,135,605 

This Statement of Financial Position is to be read in conjunction with the attached notes. 

Uscom Limited - Annual Report 2012 - 21 

 
  
 
 
 
  
  
 
  
  
  
 
  
  
 
  
  
 
  
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STATEMENT OF CHANGES IN EQUITY 
For the financial year ended 30 June 2012 

Issued 
Capital 

Options 
Reserve 

Accumulated 
Losses 

Consolidated 

$ 

$ 

$ 

Foreign 
Currency 
Translation 
Reserve 
$ 

Total 

$ 

Balance at 1 July 2010 

18,345,462 

1,041,613 

(17,000,294) 

63,254 

2,450,035 

Loss for the year 
Other Comprehensive 
Income 
Total Comprehensive 
Income for the year 
Transactions with Owners in 
their capacity as owners 
Shares Issued 
Transaction costs on Shares 
Issued 
Share-based payments 

- 

- 

- 

3,096,132 

(64,674) 

- 

- 

- 

- 

- 

- 

331,882 

(2,685,913) 

- 

(2,685,913) 

- 

8,143 

8,143 

(2,685,913) 

8,143 

(2,677,770) 

- 

- 

- 

- 

- 

- 

3,096,132 

(64,674) 

331,882 

Balance at 30 June 2011 

21,376,920 

1,373,495 

(19,686,207) 

71,397 

3,135,605 

Loss for the year 
Other Comprehensive 
Income 
Total Comprehensive 
Income for the year 
Transactions with Owners in 
their capacity as owners 
Unissued share capital 
Share-based payments 

- 

- 

- 

- 

- 

- 

(1,824,547) 

- 

(1,824,547) 

- 

2,830 

2,830 

(1,824,547) 

2,830 

(1,821,717) 

150,000 
- 

- 
6,178 

- 
- 

- 
- 

150,000 
6,178 

Balance at 30 June 2012 

21,526,920 

1,379,673 

(21,510,754) 

74,227 

1,470,066 

This Statement of Changes in Equity is to be read in conjunction with the attached notes. 

Uscom Limited - Annual Report 2012 - 22 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STATEMENT OF CASH FLOWS 
For the financial year ended 30 June 2012 

Cash flows from operating activities 
Receipts from customers 
Interest received 
Payments to suppliers and employees 
Grant and other income received 
Income tax receipt 

Consolidated 

2012 

$ 

2011 

$ 

Note 

817,190 
61,400 
(2,888,232) 
8,564 
344,896 

726,135 
41,323 
(3,337,048) 
4,737 
370,529 

Net cash used in operating activities 

21(b) 

(1,656,182) 

(2,194,324) 

Cash flows from investing activities 
Purchase of patents and trademarks 
Purchase of plant and equipment 

Net cash used in investing activities 

(74,148) 
(363) 

(65,941) 
(22,082) 

(74,511) 

(88,023) 

Cash flows from financing activities 
Issue of shares 
Share application monies received from private placement  

17 

18 

- 
150,000 

3,031,459 
- 

Net cash provided by financing activities 

150,000 

3,031,459 

Net (decrease) / increase in cash held 
Cash and cash equivalents at the beginning of the year 
Exchange rate adjustment for opening balance 
Cash and cash equivalents at the end of the year 

(1,580,693) 
2,127,265 
(2,109) 
544,463 

749,112 
1,372,843 
3,201 
2,125,156 

21 (a) 

This Statement of Cash Flows is to be read in conjunction with the attached notes. 

Uscom Limited - Annual Report 2012 - 23 

 
  
 
 
 
  
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS 

Note 1: Adoption of new and revised accounting standards 

As at the date of this report there are a number of new accounting standards and interpretations that have been 
issued but are not yet effective as detailed below: 

Australian Accounting Standards 

AASB No. 

Title 

Issue Date 

Operative Date 
(Annual reporting 
periods beginning 
on or after) 

9 

10 

11 

12 

13 

Financial Instruments 

Dec 2010 

1 Jan 2013 

Consolidation 

Aug 2011 

1 Jan 2013 

Joint Arrangements 

Aug 2011 

1 Jan 2013 

Disclosure of Interests in Other Entities 

Aug 2011 

1 Jan 2013 

Fair Value Measurement 

Sep 2011 

1 Jan 2013 

1053 

Application of Tiers of Australian Accounting Standards 

Jun 2010 

1 Jul 2013 

2010 – 2 

Amendments to Australian Accounting Standards arising from 
Reduced Disclosure Requirements 

Jun 2010 

1 Jul 2013 

2010 – 7 

Amendments to Australian Accounting Standards arising from 
AASB 9 (December 2010)  
[AASB 1, 3, 4, 5, 7, 101, 102, 108, 112, 118, 120, 121, 127, 128, 
131, 132, 136, 137, 139, 1023 & 1038 and Interpretations 2, 5, 10, 
12, 19 & 127] 

Dec 2010 

1 Jan 2013 

2010 – 8 

Amendments to Australian Accounting Standards – Deferred 
Tax: Recovery of Underlying Assets [AASB 112] 

Dec 2010 

1 Jan 2012 

2010 – 10 

2011 – 4 

Further Amendments to Australian Accounting Standards – 
Removal of Fixed Dates for First-time Adopters 
[AASB 2009-11 & AASB 2010-7] 
Amendments to Australian Accounting Standards to Remove 
Individual Key Management Personnel Disclosure Requirements 
[AASB 124] 

Dec 2010 

1 Jan 2013 

Jul 2011 

1 Jul 2013 

Australian Interpretations 

AASB No. 

Title 

Issue Date 

Operative Date 
(Annual reporting 
periods beginning 
on or after) 

20 

Stripping Costs in the Production Phase of a Surface Mine 

Nov 2011 

1 Jan 2013 

The Directors anticipate that the adoption of these Standards and Interpretations in future periods will have no 
material financial impact on the financial statements of the Consolidated Entity. 

These Standards and Interpretations will be first applied in the financial statements of the Consolidated Entity 
that relates to the annual reporting period beginning after the effective date of each pronouncement. 

 Uscom Limited - Annual Report 2012 - 24   

 
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 1: Adoption of new and revised accounting standards (continued) 

New Standards Adopted During the Year 

The Consolidated Entity has adopted all of the new, revised or amending Accounting Standards issued by the 
Australian Accounting Standards Board ('AASB') that are mandatory for the current reporting period. The 
adoption of these Accounting Standards and Interpretations did not have any impact on the financial 
performance or position of the consolidated entity. 

Any new, revised or amending Accounting Standards and Interpretations that are not yet mandatory have not 
been early adopted. 

Note 2: Statement of significant accounting policies  

Introduction 

(a) 
The financial report covers the Consolidated Entity of Uscom Ltd and its Controlled Entity.  Uscom Ltd is a listed 
public company, incorporated and domiciled in Australia.  

Operations and principal activities 
Uscom Ltd is engaged in the development, design, manufacture and marketing of non-invasive cardiac 
monitoring devices.  Uscom Ltd owns a portfolio of intellectual property relating to the technology and 
techniques associated with these devices and manages a worldwide network of distribution partners for the sale 
of its equipment to hospitals and other medical care locations. 

Scope of financial statements 
The financial report is a general purpose financial report that has been prepared in accordance with Australian 
Accounting Standards, Australian Accounting Interpretations, the Corporations Act 2001 and complies with other 
requirements of the law, as appropriate for-profit oriented entities.  

Accounting Standards include Australian Equivalents to International Financial Reporting Standards (AIFRS). 
Compliance with AIFRS ensures that the Consolidated Entity financial report conforms with International Financial 
Reporting Standards (IFRS). 

Going Concern 
The Directors have prepared the financial statements on a going concern basis, which contemplates continuity of 
normal business activities and the realisation of assets and the settlement of liabilities in the ordinary course of 
business. The Consolidated Entity has been able to secure additional funding subsequent to the Balance Sheet 
date and this is commented on further in note 29. Based on anticipated levels of operational cash flow 
requirements, the Consolidated Entity has sufficient cash to fund current operations for more than one year. 

Currency 
The financial report is presented in Australian dollars, which is the Parent Company’s functional and 
presentational currency. 

Historical Cost Convention 
This financial report has been prepared under the Historical Cost Convention. 

Reporting period 
The financial report is presented for the year ended 30 June 2012. The comparative reporting period was for the 
year ended 30 June 2011.  

Comparatives 
Where required by Accounting Standards comparative figures have been adjusted to conform with changes in 
presentation for the current financial year. 

Registered office 
Level 7, 10 Loftus Street, Sydney NSW 2000. 

Authorisation of financial report 
The financial report was authorised for issue on 30 August 2012 by the Directors. 

(b)  Overall policy 
The principal accounting policies adopted by the Consolidated Entity are stated in order to assist in the general 
understanding of the financial report. 

Uscom Limited - Annual Report 2012 - 25 

 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 2: Statement of significant accounting policies (continued) 

Significant judgment and key assumptions 

(c) 
The Directors evaluate estimates and judgements incorporated into the financial report based on historical 
knowledge and best available current information. Estimates assume a reasonable expectation of future events 
and are based on current trends and economic data, obtained both externally and within the Entity. 

The Consolidated Entity assesses impairment at each reporting date by evaluating conditions specific to the 
group that may lead to impairment of assets. Where an impairment trigger exists, the recoverable amount of the 
asset is determined. 

(d)  Financial assets and financial liabilities 
Financial assets and financial liabilities are recognised on the Statement of Financial Position when the 
Consolidated Entity becomes party to the contractual provisions of the financial instrument. 

A financial asset is derecognised when the contractual rights to the cash flows from the financial assets expire or 
are transferred and no longer controlled by the Entity. A financial liability is removed from the Statement of 
Financial Position when the obligation specified in the contract is discharged or cancelled or expires. 

Upon initial recognition a financial asset or financial liability is designated as at fair value through Profit or Loss 
except for investments in equity instruments that do not have a quoted market price in an active market and 
whose fair value cannot be reliably measured. 

A gain or loss arising from a change in the fair value of a financial asset or financial liability classified as at fair 
value through Profit or Loss is recognised in the Income Statement. 

Financial assets not measured at fair value comprise receivables and investment in subsidiary.  These are non-
derivative financial assets with fixed or determinable payments that are not quoted in an active market and are 
measured at amortised cost using the effective interest method. 

Available-for-sale financial assets include other financial assets, comprising investments in subsidiaries, not 
included in the above categories.  Available-for-sale financial assets are reflected at fair value.  Unrealised gains 
and losses arising from changes in fair value are taken directly to equity. 

Financial liabilities comprise of trade and other payables, and borrowings and are measured at amortised cost 
using the effective interest method. 

Trade accounts payable represent the principal amounts outstanding at balance date plus, where applicable, any 
accrued interest. 

The amortised cost of a financial asset or a financial liability is the amount initially recognised minus principal 
repayments, plus or minus cumulative amortisation of any difference between the initial amount and maturity 
amount and minus any write-down for impairment or uncollectibility. 

Financial assets, other than those at fair value through profit or loss, are reassessed for indicators of impairment at 
each reporting date. Financial assets are impaired where there is objective evidence that as a result of one or 
more events that occurred after the initial recognition of the financial asset the estimated future cash flows of the 
investment have been impacted. For financial assets carried at amortised cost, the amount of the impairment is 
the difference between the asset’s carrying amount and the present value of estimated future cash flows, 
discounted at the original effective interest rate. 

The carrying amount of the financial asset is reduced by the impairment loss directly for all financial assets with 
the exception of trade receivables where the carrying amount is reduced through the use of an allowance 
account. When a trade receivable is uncollectible, it is written off against the allowance account. Subsequent 
recoveries of amounts previously written off are credited against the allowance account. Changes in the carrying 
amount of the allowance account are recognised in profit and loss. 

With the exception of available-for-sale equity instruments, if, in a subsequent period, the amount of the 
impairment loss decreases and the decrease can be related objectively to an event occurring after the 
impairment was recognised, the previously recognised impairment loss is revered through profit and loss to the 
extent the carrying amount of the investment at the date the impairment is reversed does not exceed what the 
amortised cost would have been had the impairment not been recognised. 

Uscom Limited - Annual Report 2012 - 26 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 2: Statement of significant accounting policies (continued) 

(e)  Principles of consolidation 
A Controlled Entity is any entity Uscom Ltd has the power to control the financial and operating policies of so as 
to obtain benefits from its activities. 

A list of Controlled Entities is contained in note 23 to the financial statements. All Controlled Entities have a June 
financial year-end. 

All inter-company balances and transactions between Entities in the Consolidated Group, including any 
unrealised profits or losses, have been eliminated on consolidation. Accounting policies of Subsidiaries have 
been changed where necessary to ensure consistencies with those polices applied by the Parent Entity. 

On consolidation, the assets and liabilities of the Consolidated Entity’s overseas operations are translated at 
exchange rates prevailing at the reporting dates. Income and expense items are translated at the average 
exchange rates for the period unless exchange rates fluctuate significantly. Exchange differences arising, if any, 
are recognised in the foreign currency translation reserve, and are recognised in income statement on disposal of 
the foreign operation. 

Foreign currency transactions and balances 

(f) 
All foreign currency transactions during the financial year are brought to account using the exchange rate in effect 
at the date of the transaction. Foreign currency monetary items at reporting date are translated at the exchange 
rate existing at reporting date. Non-monetary assets and liabilities carried at fair value that are denominated in 
foreign currencies are translated at the rates prevailing at the date when the fair value was determined. Non-
monetary items that are measured in terms of historical cost in a foreign currency are not retranslated. 

The gains and losses from conversion of assets and liabilities, whether realised or unrealised, are included in 
profit or loss from continuous operations as they arise. 

(g)  Revenue recognition 
•  Sale of goods 
Revenue from the sale of goods is recognised when all significant risks and rewards of ownership have been 
transferred to the buyer and when the other contractual obligations of the Entity are performed. 
•  Revenue from rendering of services 
Rendering of services consists of training, repair and product maintenance supplied to customers. Revenue is 
recognised when contractual obligations are expired and services are provided. 
• 
Interest revenue is recognised on a proportional basis taking into account the interest rates applicable to the 
financial assets. 
•  Government grants 
Government grants revenue is recognised at fair value when there is reasonable assurance that the grant will be 
received and the grant conditions will be met. 

Interest revenue 

Inventories 

(h) 
Inventories are measured at the lower of cost or net realisable value. Costs are assigned on the basis of weighted 
average costs. Cost comprises all costs of purchase and conversion and an appropriate proportion of fixed and 
variable overheads, net of settlement discounts. Overheads are applied on the basis of normal operative capacity. 
The costs are recognised when materials are delivered to the Consolidated Entity. 

Property, plant and equipment 

(i) 
Property, plant and equipment are included at cost. Assets in plant and equipment are depreciated on 
diminishing value basis over their estimated useful lives covering a period of two to seven years. 

On disposal of an item of property, plant and equipment, the difference between the sales proceeds and the 
carrying amount of the asset is recognised as a gain or loss in the Income Statement. 

The depreciation rates used for each class of depreciable assets are: 

Class Of Fixed Asset  
- Plant & Equipment  
- Office Furniture & Equipment  
- Computer Software 
- Low Value Pool   

Depreciation Rate 
  10% - 40% 
  15%  
  40% 
  37.5% 

Uscom Limited - Annual Report 2012 - 27 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 2: Statement of significant accounting policies (continued) 

Intangibles 

(j) 
Patents and Trademarks are valued in the financial statements at cost of acquisition less accumulated 
amortisation and are amortised on diminishing value basis at 12.5% per annum. 

Impairment of assets 

(k) 
At each reporting date, the Consolidated Entity reviews the carrying values of its tangible and intangible assets to 
determine whether there is any indication that those assets have been impaired.  If such an indication exists, the 
recoverable amount of the asset, being the higher of the asset’s fair value less costs to sell and value in use, is 
compared to the asset’s carrying value.  Any excess of the asset’s carrying value over its recoverable amount is 
expensed to the income statement. In assessing value in use, the estimated future cash flows discounted to their 
present value using a pre-tax discount rate. 

Leases 

(l) 
Lease of assets where substantially all the risks and benefits incidental to the ownership of the asset, but not the 
legal ownership, are transferred to the Consolidated Entity were classified as finance leases. Finance leases are 
capitalised, recording an asset and a liability equal to the present value of the minimum lease payments, 
including any guaranteed residual values.  

Leased assets are amortised on diminishing value basis over their estimated useful lives where it is likely that the 
Consolidated Entity will obtain ownership of the asset or over the term of the lease. Lease payments are allocated 
between the reduction of the lease liability and the lease interest expense for the period. 

Lease payments for operating leases, where substantially all the risks and benefits remain with the lessor, are 
recognised as an expense on a straight line basis over the lease term unless another systematic basis is more 
representative of the time pattern in which benefits are diminished. 

Lease incentives under operating leases are recognised as liabilities.  The incentives are recognised as a 
reduction of expenses on a straight line basis unless another systematic basis is more representative of the time 
pattern in which benefits are diminished. 

(m)  Cash and cash equivalents 
Cash and cash equivalents comprise cash on hand and at call deposits with banks or financial institutions. 

Investments 

(n) 
Investments in Controlled Entities are carried at the lower of cost and recoverable amount. 

(o)  Research & development expenditure 
Research & development costs are charged to the Income Statement as incurred, or deferred where it is probable 
that sufficient future benefits will be derived so as to recover those deferred costs. 

(p)  Foreign currency transactions and balances 
Foreign currency transactions during the year are converted to Australian dollars at the rates of exchange 
applicable at the dates of the transactions. Amounts receivable and payable in foreign currencies at balance 
sheet date are converted at the rates of exchange ruling at that date.  

The gains and losses from conversion of assets and liabilities, whether realised or unrealised, are included in 
profit or loss from continuous operations as they arise. 

Income tax 

(q) 
Income taxes are accounted for using the Balance Sheet liability method whereby: 
•  The tax consequences of recovering (settling) all assets (liabilities) are reflected in the financial statements; 
•  Current and deferred tax is recognised as income or expenses except to the extent that the tax relates to 

equity items or to a business combination; 

•  A deferred tax asset is recognised to the extent that it is probable that future taxable profit will be available to 

realise the asset; 

•  Deferred tax assets and liabilities are measured at the tax rates that are expected to apply to the period when 

the asset is realised or the liability settled. 

The charge for current income tax expense/credit is based on the profit or loss for the year adjusted for any non 
assessable or disallowed items. It is credited using tax rates that have been enacted or are substantively enacted 
by the reporting date. 

Uscom Limited - Annual Report 2012 - 28 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 2: Statement of significant accounting policies (continued) 

Deferred tax is accounted for using the Balance Sheet liability method in respect of temporary differences arising 
between the tax bases of assets and liabilities and their carrying amounts in the financial statements. 

Deferred tax is calculated at the tax rates that are expected to apply to the period when the asset is realised or 
liability is settle. Deferred tax is credited in the income statement except where it relates to items that may be 
credited directly to equity, in which case the deferred tax is adjusted directly against equity. 

Deferred income tax assets are recognised to the extent that it is probable that future tax profits will be available 
against which deductible temporary differences can be utilised. 

The amount of benefits brought to account or which may be realised in the future is based on the assumption 
that no adverse change will occur in income taxation legislation and the anticipation that the Consolidated Entity 
will derive sufficient future assessable income to enable the benefit to be realised and comply with the conditions 
of deductibility imposed by the law. 

Short term employee benefits 

(r) 
Short term employee benefits are employee benefits (other than termination benefits and equity compensation 
benefits) which fall due wholly within 12 months after the end of the period in which employee services are 
rendered. They comprise wages, salaries, social security obligations, short-term compensation absences, profit 
sharing and bonuses payables within 12 months and non-mandatory benefits such as medical care, housing, car 
and service goods. 

The provision for employee entitlements to wages, salaries and annual leave represents the amount that the 
Consolidated Entity has a present obligation to pay resulting from employee services provided up to reporting 
date. The provision has been calculated after taking into consideration estimated future increases in wages and 
salaries and past experience regarding staff departures and includes related on-costs. 

The undiscounted amount of short-term benefits expected to be paid is recognised as an expense. 

Long term employee benefits 

(s) 
Long term employee benefits include long-service leave, long-term disability benefits, deferred compensation 
and profit sharing and bonuses payable 12 months or more after the end of the period in which employee 
services are rendered. 

Uscom Ltd has adopted an Employee Share Option Plan for the benefit of Executive and Non-Executive Directors 
and full-time or part-time staff members employed by the Consolidated Entity. Refer note 19 to the financial 
statements for details. 

An Executive Share Option Plan has also been developed to provide approved participants further incentive in 
their performance for the Consolidated Entity and an opportunity to acquire an ownership interest in the 
Consolidated Entity. 

Share-based payment arrangement 

(t) 
Goods or services received or acquired in a share-based payment transaction are recognised as an increase in 
equity if the goods or services were received in an equity-settled share based payment transaction or as a liability 
if the goods and services were acquired in a cash settled share based payment transaction. 

For equity-settled share based transactions, goods or services received are measured directly at the fair value of 
the goods or services received provided this can be estimated reliably. If a reliable estimate cannot be made the 
value of the goods or services is determined indirectly by reference to the fair value of the equity instrument 
granted. 

Transactions with employees and others providing similar services are measured by reference to the fair value at 
grant date of the equity instrument granted. 

(u)  Goods and services tax (GST) 
Revenues, expenses and assets are recognised net of the amount of GST, except where the amount of GST 
incurred is not recoverable from the Australian Tax Office. In these circumstances the GST is recognised as part of 
the cost of acquisition of the asset or as part of an item of the expense. Receivables and payables in the 
Statement of Financial Position are shown inclusive of GST. 

Uscom Limited - Annual Report 2012 - 29 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 2: Statement of significant accounting policies (continued) 

(v)  Receivables 
Trade receivables and other receivables represent the principal amounts due at reporting date plus accrued 
interest and less, where applicable, any unearned income and provision for doubtful accounts. An estimated 
doubtful debt is made when collection of the full amount is no longer probable. 

(w)  Contingent liabilities 
A contingent loss is recognised as an expense and a liability if it is probable that future events will confirm that, 
after taking into account any related probable recovery, an asset has been impaired or a liability incurred and, a 
reasonable estimate of the amount of the resulting loss can be made. 

(x)  Warranties 
Provision is made in respect of the Consolidated Entity's estimated liability on all products and services under 
warranty at reporting date. The provision is measured at the present value of future cash flows estimated to be 
required to settle the warranty obligation. The future cash flows have been estimated by reference to the 
Consolidated Entity's history of warranty claims. 

(y)  Events after the reporting date 
Assets and liabilities are adjusted for events incurring after the reporting date that provide evidence of conditions 
existing at the reporting date.  Important after reporting date events which do not meet these criteria are 
disclosed in note 29 to the financial statements. 

Note 3: Revenue 
Operating revenue 
Sale of goods 
Other revenue 
Interest received 
Grants received - VAT return 
Miscellaneous income 
Total other income 

Total revenues from continuing operations 

Note 4: Expenses from continuing activities, excluding finance costs 

Depreciation and amortisation expenses 
Impairment of patents 
Employee benefits expense  
Research and development expenses 
Advertising and marketing expenses 
Occupancy expenses 
Auditors remuneration (audit) 
Auditors remuneration (audit review) 
Regulatory expenses 
Administrative expenses 
Exchange losses 
Total expenses from continuing activities, excluding finance costs 
Operating lease expenses of $139,544 in 2012 (2011: $131,849) are included in 
occupancy expenses above 

Consolidated 

2012 

$ 

2011 

$ 

794,135 

834,813 

61,400 
4,928 
3,636 
69,964 

41,323 
1,555 
3,182 
46,060 

864,099 

880,873 

103,465 
80,497 
944,173 
509,858 
544,746 
152,531 
39,000 
18,000 
55,577 
427,832 
6,296 
2,881,975 

103,412 
11,731 
1,254,616 
502,037 
913,149 
153,683 
39,000 
17,000 
70,424 
444,602 
150,487 
3,660,141 

Uscom Limited - Annual Report 2012 - 30 

 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 5: Income tax credit 
Major components of income tax credit 
Current income tax credit 

Income tax credit 

Consolidated 

2012 

$ 

2011 

$ 

406,253 

406,253 

344,896 

344,896 

Reconciliation between income tax credit and prima facie tax on accounting 
loss  

Accounting loss before income tax 

2,230,800 

3,030,809 

Tax benefit at 30% in Australia, 15% in USA (2011: 30% in Australia) 
Tax effect on non deductible expenses 
Temporary differences 
Deferred tax asset not brought to account 
Research and development tax offset - current year 

Income tax credit 

678,128 
(289,844) 
(37,077) 
(351,207) 
406,253 

406,253 

902,660 
(372,527) 
(19,611) 
(510,522) 
344,896 

344,896 

As at 30 June 2012, the Consolidated Entity had estimated unrecouped operating income tax losses of $14,923,319 
(2011: $13,832,400). The benefit of these losses of $4,300,155 (2011: $3,957,157) has not been brought to account as 
realisation is not probable. The benefit will only be obtained if: 
•  The Consolidated Entity derives future assessable income of a nature and an amount sufficient to enable the 

benefits from the deductions for the losses to be realised; 

•  The Consolidated Entity continues to comply with the conditions for deductibility imposed by the law; 
•  No changes in tax legislation adversely affect the Consolidated Entity in realising the benefit from the deduction 

for the losses. 

Note 6: Accumulated losses 
Accumulated losses at the beginning of the financial year 
Net loss attributable to members of the Entity 

Accumulated losses at the end of the financial year 

Note 7: Earnings per share  
Loss after tax used in calculation of basic and diluted EPS 

(19,686,207) 
(1,824,547) 

(17,000,294) 
(2,685,913) 

(21,510,754) 

(19,686,207) 

(1,824,547) 
Number 

(2,685,913) 
Number 

Weighted average number of ordinary shares during the year used in calculation 
of basic EPS 
Weighted average number of options outstanding 
Weighted average number of ordinary shares outstanding during the year used in 
calculation of diluted EPS 
(5.8) 
Basic earnings per share (cents per share) 
(5.8) 
Diluted earnings per share (cents per share) 
The options in existence have an anti-dilutive effect on EPS, therefore there is no difference between basic earnings 
per share and diluted earnings per share as shown above. After the reporting date, 2,000,000 ordinary shares were 
issued on 2 July 2012 which have not been included in the calculations of basic and dilutive EPS. 

52,124,488 

54,719,283 

46,103,168 

50,811,524 

(3.5) 
(3.5) 

4,708,356 

2,594,795 

Note 8: Cash and cash equivalents  
Cash on hand 
Bank: Cheque accounts 
Bank: Cash management 
Bank: Term deposits 
Bank: Deposit at call 

Total cash and cash equivalents 

185 
463,633 
28,758 
35,230 
16,657 

544,463 

185 
747,600 
34,745 
1,235,230 
107,396 

2,125,156 

Uscom Limited - Annual Report 2012 - 31 

 
  
 
  
 
 
 
 
  
 
 
 
 
 
 
  
  
  
  
  
 
  
  
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 9: Trade and other receivables 
Current 
Trade receivables 

Total current receivables 

Consolidated 

2012 

$ 

2011 

$ 

140,936 

140,936 

163,991 

163,991 

Trade receivables are non-interest bearing and on an average of 45 day terms. Details of trade receivables due but 
not impaired are disclosed in note 22. 

Note 10: Inventories 
Current inventories at cost 
Raw materials 
Finished products  

Total inventories 

Note 11: Tax asset 
Income tax credit 

Total tax asset 

Note 12: Plant and equipment 
Plant and equipment at cost 
Accumulated depreciation 

Office furniture and equipment at cost 
Accumulated depreciation 

Computer software at cost 
Accumulated depreciation 

Low value asset pool at cost 
Accumulated depreciation 

113,367 
77,663 

191,030 

406,253 

406,253 

148,903 
64,979 

213,882 

344,896 

344,896 

556,216 
(492,603) 
63,613 

546,714 
(459,480) 
87,234 

59,166 
(56,326) 
2,840 

22,120 
(21,505) 
615 

32,089 
(30,899) 
1,190 

59,166 
(55,825) 
3,341 

22,120 
(20,981) 
1,139 

31,726 
(30,151) 
1,575 

Total plant and equipment 

68,258 

93,289 

Movements in carrying amounts 

Plant and 
equipment 

Office 
furniture 

Computer 
software 

Low value 
asset pool 

Useful life 

2-7 years 
$ 

2-7 years 
$ 

3 years 
$ 

3 years 
$ 

Consolidated Entity 
Carrying amount at 1 July 2011 
Additions 
Disposals 
Depreciation expense 
Effects of foreign currency exchange differences 

Carrying amount at 30 June 2012 

87,234 
9,397 
- 
(33,027) 
9 

63,613 

3,341 
- 
- 
(501) 
- 

2,840 

1,139 
- 
- 
(524) 
- 

615 

1,575 
363 
- 
(748) 
- 

1,190 

Uscom Limited - Annual Report 2012 - 32 

 
  
 
  
  
  
  
  
  
  
  
  
 
 
 
 
  
  
 
 
  
  
 
 
  
  
 
 
  
  
 
 
 
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 13: Intangible assets 
Non-current 
Patents at cost 
Additions 
Impairment at cost 
Accumulated amortisation, net of impairment 

Carrying amount at 30 June 2012 

Movements in carrying amounts 
Carrying amount at 1 July 2011 
Additions 
Amortisation 
Impairment 

Carrying amount at 30 June 2012 

Consolidated 

2012 

$ 

2011 

$ 

839,505 
74,147 
(151,322) 
(326,858) 

435,472 

510,487 
74,147 
(68,665) 
(80,497) 

435,472 

785,795 
65,941 
(12,232) 
(329,017) 

510,487 

525,486 
65,941 
(69,209) 
(11,731) 

510,487 

Intangible Assets comprise Intellectual Property in the form of Patents. The Patents have finite useful lives. The 
current amortisation charge in respect of Patents is included under Expenses from Continuing Activities in the 
Income Statement. An impairment charge of $80,497 has been recognised in the current year (2011: $11,731) in 
relation to Patents carried in Australia where there have been no sales for several years. The impairment charge is 
recorded under Expenses from Continuing Activities.  

Note 14: Other assets  
Current  
GST receivable 
Prepayments 

Total other current assets 

Note 15: Trade and other payables 
Current 
Trade payables 
Sundry payables and accrued expenses 
Employee related payables 

Total payables 

Note 16: Provisions 
Short term 
Provision for annual leave 

Long term 
Provision for long service leave 
Provision for warranties 

11,067 
30,879 

41,946 

37,584 
41,019 
29,754 

19,811 
52,778 

72,589 

54,387 
62,051 
31,835 

108,357 

148,273 

122,983 
122,983 

119,734 
7,218 
126,952 

142,269 
142,269 

91,248 
6,895 
98,143 

(a) Aggregate employee benefits 

242,717 

233,517 

(b) Movement in employee benefits 
Balance at beginning of the year 
Additional provision 
Amounts used 

Balance at end of the year 

(c) Number of employees at year-end 

233,517 
129,767 
(120,567) 

242,717 

205,132 
98,264 
(69,879) 

233,517 

Number 

Number 

11 

14 

Uscom Limited - Annual Report 2012 - 33 

 
  
 
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 17: Issued capital 
Issued capital 
Fully paid ordinary shares 

Total contributed equity 

Movement in issued capital 
Shares on issue at the beginning of the year 
9,437,835 ordinary shares issued at 30 cents 
882,606 ordinary shares issued at 30 cents 
Share issue costs 

Ordinary shares at the end of the year 

Fully paid ordinary shares 
Ordinary shares at the beginning of the year 
9,437,835 ordinary shares issued by private placement 
882,606 ordinary shares issued by SPP 

Total ordinary shares at the end of the year 

Consolidated 

2012 

$ 

2011 

$ 

21,376,920 

21,376,920 

21,376,920 

21,376,920 

21,376,920 
- 
- 
- 

18,345,462 
2,831,350 
264,782 
(64,674) 

21,376,920 

21,376,920 

Number  
52,124,488 
- 
- 

Number  
41,804,047 
9,437,835 
882,606 

52,124,488 

52,124,488 

The Company’s authorised share capital amounted to 52,124,488 ordinary shares of no par value. 

Fully paid ordinary shares participate in dividends and the proceeds on winding up of the Company in proportion to 
the number of shares held. At shareholders meetings, each ordinary share is entitled to one vote when a poll is 
called, or via a show of hands. 

After the reporting date, 2,000,000 ordinary shares were issued on 2 July 2012. 

Note 18: Unissued capital 
Unissued capital 
Application monies received in advance for share allotment 

Total contributed equity 

Movement in unissued capital 
Balance at the beginning of the year 
Application monies received in advance for share allotment 

Unissued capital at the end of the year 

Consolidated 

2012 

$ 

2011 

$ 

150,000 

150,000 

- 
150,000 

150,000 

- 

- 

- 
- 

- 

After the reporting date, 2,000,000 ordinary shares were issued on 2 July 2012 at 7.5 cents. 

Note 19: Options reserve 
The Consolidated Entity has adopted an Employee Share Option Plan and an Executive Share Option Plan for the 
benefit of Executive Directors and full-time or part-time staff members employed by the Consolidated Entity. At the 
date of this Report the following options had been issued pursuant to the Employee Share Option Plan. Each 
option was issued for a period of 4 years and vest in tranches of 25% after 9 months, 12 months, 24 months and 36 
months. Exercise price is based on 85% of the average ASX closing price for the 5 days prior to offer/acceptance of 
the options, in accordance with the Employee Share Option Plan and the Executive Share Option Plan.  The Board 
may impose conditions, including performance related conditions, on the right to exercise any options granted 
under the Executive Share Option Plan. 

During the year, 400,000 options were granted to employees under the Employee Share Option Plan and 900,000 
options were granted to executives and consultants under the Executive Share Option Plan. 

Uscom Limited - Annual Report 2012 - 34 

 
  
 
  
  
  
  
  
  
  
  
  
  
 
 
 
 
 
 
  
 
  
  
  
  
  
  
  
  
  
  
 
  
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 19: Options reserve (continued) 
Effect of share-based payment transactions 
Share Option Plan 
Options reserve balance at the beginning of the year 
Expenses arising from share-based payment transactions 
Options reserve balance for Share Option Plan at the end of the year 

OSI Systems 
Right to participate in options 

Option reserve at the end of the year 

Consolidated 

2012 

$ 

2011 

$ 

1,373,494 
6,178 
1,379,672 

1,041,612 
331,882 
1,373,494 

1 

1 

1,379,673 

1,373,495 

Movement during the financial year 

Opening number of options 
Granted during the financial year – Directors 
Option Deed 
Granted during the financial year – Employees & 
Executives 
Lapsed during the financial year 

Closing number of options 

Number of 
Options 2012 

7,710,000 

Weighted 
average 
exercise price 
1.10 

Number of 
options 2011 

3,780,000 

Weighted 
average 
exercise price 
0.36 

- 

- 

4,400,000 

1,300,000 

(5,450,000) 

3,560,000 

0.06 

1.40 

0.25 

- 

(470,000) 

7,710,000 

1.69 

- 

0.65 

1.10 

Details of options outstanding as at end of the year 

Holders No. 

Grant date 

20 November 2008 
17 December 2008 

7 (Employees) 
1 (Investor) 
10 (Employees & 
Executives) 

Total 

Exercisable
at 30 June 
2012 
%
100% 
100% 

 Expiry date 

20 November 2012 
17 December 2013 

30 June 2012 
Outstanding 
Option 
No. 
260,000 
2,000,000 

Exercise 
Price 

$ 
0.29 
0.375 

Issued 
date fair 
value 
$
0.19 
0.12 

29 March 2012 

0% 

29 March 2016 

1,300,000 

0.0595 

0.06 

3,560,000 

Fair value 
Fair value was measured using Blackscholes and the inputs to it were as follows: 
Weighted average share price  Range from $0.06 to $1.10 
Exercise price 
Option life 
Risk-free interest rate 
Expected dividends 
Expected volatility* 
* Historical volatility has been the basis for determining the expected share price volatility as it is assumed that it is indicative of the future trade, which may not eventuate. 

260,000 at $0.29; 2,000,000 at $0.375; 1,300,000 at $0.0595 
4-5 years 
Range from 4.17% to 4.6% 
0 
Range from 62% to 65% 

Note 20: Translation reserve 
Opening balance 
Translation of financial statements of foreign Controlled Entity 

Closing balance 

Consolidated 

2012 

$ 

71,397 
2,830 

74,227 

2011 

$ 

63,254 
8,143 

71,397 

Uscom Limited - Annual Report 2012 - 35 

 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 21: Cash flow information 
(a) Reconciliation of cash 
Cash at bank and on hand 

Total cash at end of year 

(b) Reconciliation of cash flow from operations to loss from continuing operations 
after income tax 
Loss from continuing operations after income tax 
Non cash flows in loss from continuing operations 

Depreciation 
Amortisation 
Impairment of patents 
Options reserve 

Translation reserve 
(Increase)/Decrease in assets 

Trade debtors 
Inventories 
Prepayments 
Income tax 
GST assets 

 Increase/(Decrease) in liabilities 

Trade payables 
Sundry payables and accrued expenses 
Employee related payables 
Employee provisions 
Other provisions 

Net cash used in operating activities  

Note 22: Financial instruments 

Consolidated 

2012 

$ 

2011 

$ 

544,463 

544,463 

2,125,156 

2,125,156 

(1,824,547) 

(2,685,913) 

34,800 
68,665 
80,497 
6,178 
2,822 

23,055 
13,455 
21,899 
(61,357) 
8,744 

(16,803) 
(21,032) 
(2,081) 
9,200 
323 

34,203 
69,209 
11,731 
331,882 
8,213 

(108,678) 
105,657 
1,547 
25,633 
4,890 

(37,854) 
16,936 
(1,780) 
28,385 
1,615 

(1,656,182) 

(2,194,324) 

Significant accounting policies 

(a) 
Details of the significant accounting policies and methods adopted, including the criteria of recognition, the basis 
of measurement and the basis on which income and expenses are recognised, in respect of each class of financial 
asset, financial liability and equity instrument are disclosed in note 2 to the financial statements.  

(b)  Capital risk management 
The Consolidated Entity manages its capital to ensure that companies in the Consolidated Entity are able to 
continue as a going concern. The capital structure of the Entity consists of cash and cash equivalents (note 8 on 
page 31) and equity attributable to equity holders of the Parent, comprising issued capital (note 17 on page 34), 
and accumulated losses (note 6 on page 31). 

Financial instruments 

(c) 
At 30 June 2012, there were no outstanding contracts. 

(d)  Financial risk management objectives 
The Consolidated Entity’s principal financial instruments are cash and term deposit accounts. Its financial 
instruments risk is with interest rate risk on its cash and term deposits and liquidity risk for its term deposits.  

The Consolidated Entity does not enter into or trade financial instruments, including derivative financial 
instruments, for speculative purposes. The Board is updated monthly by management as to the amounts of funds 
available to the Consolidated Entity from either cash in the bank or term deposits, and continually monitors 
interest rate movements. 

Uscom Limited - Annual Report 2012 - 36 

 
  
 
  
  
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 22: Financial instruments (continued) 

(e)  Foreign currency risk management 
The Consolidated Entity undertakes certain transactions denominated in foreign currencies, hence exposures to 
exchange rate fluctuations arise. The Consolidated Entity does not have any forward foreign exchange contracts 
as at 30 June 2012 and is exposed to foreign currency risk on sales and purchases dominated in a currency other 
than Australian dollars.  

The currencies given rise to this risk is primarily the US Dollar, Euro and British Pound. The Consolidated Entity 
incurs costs in US Dollars for its operations which provide a natural hedge for a portion of income denominated in 
US Dollars. 

The carrying amount of the Consolidated Entity’s foreign currency denominated monetary assets and monetary 
liabilities at the reporting date is as follows: 

Consolidated 

Cash 
Current trade debtors 
Current trade creditors 

Cash 
Current trade debtors 
Current trade creditors 

Current trade debtors 

2012 

US$ 

211,041 
136,890 
20,385 

€ 

63,323 
5,350 
2,052 

£ 

- 

2011 

US$ 

90,224 
146,410 
10,434 

€ 

45,555 
9,150 
5,891 

£ 

10,200 

Foreign currency sensitivity 

(f) 
The Consolidated Entity is mainly exposed to exchange rate risks arising from movements in the US Dollar, Euro 
and British Pound against the Australian Dollar, and the US Dollar from the translation of the operations of its 
Controlled Entity. 

The analysis below demonstrates the impact of a 10% movement of US Dollar and a 5% movement of Euro and 
British Pound rates against the Australian Dollar with all other variables held constant. 10% and 5% are the 
sensitivity rates used when reporting foreign currency risk internally to key management personnel and represents 
management’s assessment of the possible change in foreign exchange rates. 

Profit/Loss - increase 10% (US$) and 5% (€) & (£) 
                   - decrease 10% (US$) and 5% (€) & (£) 

Consolidated 

2012 

$ 
(73,584) 
73,584 

2011 

$ 
(74,279) 
74,279 

Interest rate risk management 

(g) 
The Consolidated Entity does not have any external loans or borrowings as at 30 June 2012 and is not exposed to 
interest rate risks related to debt.  

The Consolidated Entity is exposed to interest rate risk as companies in the Consolidated Entity hold cash and 
term deposits at both fixed and floating interest rates. The risk is managed by the Consolidated Entity 
maintaining an appropriate mix between both rates.  

Management continually monitor its cash requirements through forecasts and cash flow projections and move 
funds between fixed and variable interest instruments to hold the maximum amount possible in instruments 
which pay the greater rate of interest. This limits the amount of risk associated with setting a policy on the mix of 
funds to be held in fixed or variable interest rate instruments. 

Uscom Limited - Annual Report 2012 - 37 

 
 
 
 
  
 
  
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 22: Financial instruments (continued) 

Interest rate sensitivity 

(h) 
A 100 basis point increase or decrease is used when reporting interest rate risk internally to key management 
personnel and represents management’s assessment of the possible change in interest rates. 

Profit/Loss - increase 100 basis points 
                   - decrease 100 basis points 

Consolidated 

2012 

$ 
6,140 
(6,140) 

2011 

$ 
4,132 
(4,132) 

(i)  Credit risk management 
Credit risk represents the loss that would be recognised if counterparties defaulted on its contractual obligations. 
The Consolidated Entity’s exposure and the credit ratings of its counterparties are continuously monitored and 
the aggregate value of transactions concluded is spread among approved counterparties. Credit exposure is 
controlled by counterparty limits that are reviewed and approved by the management annually. Ongoing credit 
evaluation is also performed on the financial condition of accounts receivable. 

The Consolidated Entity does not have significant credit risk exposure to any single counterparty or any group of 
counterparties having similar characteristics; because the current major counterparties are alliance distributors 
and public hospitals with approved funds available prior to purchases under most circumstances.  

The credit risk on financial assets of the Consolidated Entity have been recognised on the Statement of Financial 
Position, is the carrying amount, net of any allowance for doubtful debts. Credit risk in respect of cash and 
deposit is minimised as counterparties are recognised financial intermediaries with acceptable credit ratings 
determined by a recognised rating agency. 

 Past due but not impaired 

0 - 45 days 
46 – 90 days 
Over 90 days 

Total 

Consolidated 

2012 

$ 
17,035 
- 
15,821 

32,856 

2011 

$ 
10,662 
- 
- 

10,662 

No bad debt was written off during the year (2011: $Nil).  There was no doubtful debt provision as at 30 June 2012 
(2011: Nil). 

Management considers the above debts to be recoverable based on the continuing work with the parties 
involved and the progress they have made in the market, and the recognised long lead time associated with 
selling capital item, hence no impairment allowance is required. 

Liquidity risk management 

(j) 
The objective for managing liquidity risk is to ensure the business has sufficient working capital or access to 
working capital as and when required.  

The Consolidated Entity limits its exposure to liquidity risk by holding the majority of its assets in cash or term 
deposits which can be quickly converted to cash if required.  

The carrying amounts of financial assets and financial liabilities recorded at cost approximate their fair values. 

The following table details the Consolidated Entity’s remaining contractual maturity for its non-derivative financial 
assets and liabilities. The table has been drawn up based on the undiscounted cash flows expected to be 
received/paid by the Consolidated Entity. 

Uscom Limited - Annual Report 2012 - 38 

 
 
  
 
  
 
 
 
 
  
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 22: Financial instruments (continued) 

 Consolidated 

Fixed interest rate maturing 

Weighted 
Average 
effective 
interest 
Rate % 

Floating
interest 

Within 1
year 

1 to 5 
years 

Non-
interest 
bearing 

Total 

$ 

$ 

$ 

$ 

$ 

2012 
Financial assets 
Cash 
Trade receivables 
Other receivables 

Total financial assets 

Financial liabilities 
Trade creditors 
Payables 

Total financial liabilities 

Net financial assets 

2011 
Financial assets 
Cash 
Trade receivables 
Other receivables 

Total financial assets 

Financial liabilities 
Trade creditors 
Payables 

Total financial liabilities 

Net financial assets 

1.3 

- 

4.9 

- 

509,233 
- 
- 

509,233 

35,230 
- 
- 

35,230 

- 
- 

- 

- 
- 

- 

509,233 

35,230 

889,926 
- 
- 

1,235,230 
- 
- 

889,926 

1,235,230 

- 
- 

- 

- 
- 

- 

889,926 

1,235,230 

Reconciliation of net financial assets to net assets 
Net financial assets as above 
Non financial assets and liabilities 
Current tax receivable 
Inventories 
Prepayments 
Plant and equipment 
Intangible assets 
Accruals 
Provisions 

Net assets per Statement of Financial Position 

Note 23: Related party disclosures 

- 
- 
- 

- 

- 
- 

- 

- 

- 
- 
- 

- 

- 
- 

- 

- 

- 
140,936 
11,067 

152,003 

37,584 
29,754 

67,338 

544,463 
140,936 
11,067 

696,466 

37,584 
29,754 

67,338 

84,665 

629,128 

- 
163,991 
19,811 

2,125,156 
163,991 
19,811 

183,802 

2,308,958 

54,387 
31,835 

86,222 

54,387 
31,835 

86,222 

97,580 

2,222,736 

2012 
$ 
629,128 

2011 
$ 
2,222,736 

406,253 
191,030 
30,879 
68,258 
435,472 
(41,019) 
(249,935) 

344,896 
213,882 
52,778 
93,289 
510,487 
(62,051) 
(240,412) 

1,470,066 

3,135,605 

Transactions between related parties are on normal commercial terms and conditions, no more favourable than 
those available to other parties unless otherwise stated. 

Parent and Controlled Entity 
Parent Entity 
Significant investments in subsidiaries:  
Country of subsidiary incorporation:  
Proportion of ownership interest: 
Consolidated 
The Parent and Ultimate Parent Entity is Uscom Ltd.  

Uscom, Inc. 
U.S.A 
100% 

Uscom Limited - Annual Report 2012 - 39 

 
 
  
  
 
  
 
  
  
  
  
  
 
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
  
 
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 23: Related party disclosures (continued) 
Transactions between related parties 
Other related parties 
Company Matters Pty Limited 
As a Company Secretary of Uscom Ltd, Mr Tom Rowe provides services to the 
Company through Company Matters Pty Limited. 
Services rendered  

CFO Strategic Chartered Accountants 
As a Company Secretary and Chief Financial Officer of Uscom Ltd up to 30th 
November 2011, Mr Daniel Fah provided services to the Company through CFO 
Strategic Chartered Accountants. 
Services rendered  

Ecrucis Pty Limited 
As a Director of Uscom Ltd up to 22nd November 2011, Mr Phil Kiely provided 
services to the Company through Ecrucis Pty Limited. 
Services rendered  

3 Pools Pty Limited 
Rent received from 3 Pools Pty Limited, a company owned by Mr Jochen Bonitz 
who was a director of Uscom Limited up to 22nd November 2011. 

Consolidated 

2012 

$ 

2011 

$ 

1,965 

- 

26,360 

65,994 

60,000 

108,000 

3,636 

3,182 

Key management personnel 
The following were key management personnel of the Consolidated Entity at any time during the reporting period 
and unless otherwise indicated were key management personnel for the entire period: 

Non-Executive Directors 
Bruce Rathie, Non-Executive Director  (ceased on 30th August 2011) 
Jochen Bonitz, Non-Executive Director  (ceased on 22nd November 2011) 
Sheena Jack, Non-Executive Director  (commenced on 25th November 2011) 
Christian Bernecker, Non-Executive Director  (commenced on 25th November 2011) 
Executive Directors 
Rob Phillips, Executive Director, Chairman, Chief Executive Officer   
Phil Kiely, Executive Chairman  (ceased on 22nd November 2011) 
Senior Executives 
Daniel Fah, Chief Financial Officer, Company Secretary  (ceased on 30th November 2011) 
Tom Rowe, Company Secretary  (commenced on 7th December 2011) 
Nick Schicht, General Manager  
Deb Johnson, VP Sales and Marketing  (ceased on 8th June 2012) 
Joe Trygar, Chief Executive Officer  (from 16th September 2011 to 2nd December 2011) 

For further remuneration information of key management personnel refer to the remuneration report in the 
Directors’ report on pages 13 to 17. 

The aggregate compensation made to Directors and other members of key management personnel of the 
Company and the Consolidated Entity is set out below: 

Short-term employee benefits 
Post-employment benefits 
Other payments 
Share-based payment 

Total key management personnel remuneration 

Consolidated 

2012 

$ 
540,708 
61,746 
102,648 
1,206 

706,308 

2011 

$ 
551,654 
55,987 
187,406 
327,731 

1,122,778 

Uscom Limited - Annual Report 2012 - 40 

 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 23: Related party disclosures (continued) 

Number of options over ordinary shares held by Key Management Personnel 

Balance 

Granted 

Exercised 

Lapsed / 
Transferred 
out 

Balance 

Total vested 

During 
FY2012 
No.

During
 FY2012 
No.

During FY2012 

30 June 2012 

No.

No. 

& exercisable 
30 June 2012 
No.

Non-Executive Director 
S Jack (from 25 Nov 2011) 
C Bernecker (from 25 Nov 2011) 
B Rathie (to 30 Aug 2011) 
J Bonitz (to 22 Nov 2011) 
Executive Director 
R Phillips 
P Kiely (to 22 Nov 2011) 
Senior Executive 
T Rowe (from 7 Dec 2011) 
N Schicht 
D Fah (to 30 Nov 2011) 
D Johnson (to 8 Jun 2012) 
J Trygar (to 2 Dec 2011) 

Total 

1 July 2011 

No. 

- 
- 
- 
400,000  

- 
4,000,000 

- 
- 
- 
- 

- 
- 

- 
100,000  
50,000 
- 
- 

- 
300,000 
- 
150,000 
- 

4,550,000 

450,000 

- 
- 
- 
- 

- 
- 

- 
- 
- 
- 
- 

- 

- 
- 
- 
(400,000) 

- 
(4,000,000) 

- 
- 
(50,000) 
(150,000) 
- 

(4,600,000) 

- 
- 
- 
- 

- 
- 

- 
- 
- 
- 

- 
- 

- 
400,000 
- 
- 
- 

400,000 

- 
100,000 
- 
- 
- 

100,000 

Number of shares held by Key Management Personnel (including indirect interest) 

Balance 
1 July 2011 
No. 

Received as 
Remuneration 
No. 

Options 
Exercised 
No. 

Net change 
Other* 
No. 

Balance 
30 June 2012 
No. 

Non-Executive Director 
S Jack (from 25 Nov 2011) 
C Bernecker (from 25 Nov 2011) 
B Rathie (to 30 Aug 2011) 
J Bonitz (to 22 Nov 2011) 
Executive Director 
R Phillips 
P Kiely (to 22 Nov 2011) 
Senior Executive 
T Rowe (from 7 Dec 2011) 
N Schicht 
D Fah (to 30 Nov 2011) 
D Johnson (to 8 Jun 2012) 
J Trygar (to 2 Dec 2011) 

- 
- 
93,809 
- 

16,996,733 
333,333 

- 
18,200 
5,000 
5,100 
- 

Total 

17,452,175 

- 
- 
- 
- 

- 
- 

- 
- 
- 
- 
- 

- 

- 
- 
- 
- 

- 
- 

- 
- 
- 
- 
- 

- 

80,000 
- 
(93,809) 
- 

80,000(1) 
- 
-(2) 
- 

- 
(333,333) 

16,996,733(3) 
-(4) 

- 
- 
(5,000) 
(5,100) 
- 

- 
18,200(5) 
-(6) 
-(7) 
- 

(357,242) 

17,094,933 

*Net change other refers to share purchased or sold during the financial year, or cessation of categorisation as a Director or Senior Executive. 
(1) All these ordinary shares are held by family associate. 

(2) Bruce Rathie ceased to be key management personnel on 30 August 2011. 

(3) 382,924 of these ordinary shares are held by Australian Cardiac Sonography Pty Ltd as trustee for the Phillips Superannuation. 

(4) Phil Kiely ceased to be key management personnel on 22 November 2011. 

(5) 10,000 of these ordinary shares are held by family associate. 

(6) Daniel Fah ceased to be key management personnel on 30 November 2011. 

(7) Deb Johnson ceased to be key management personnel on 8 June 2012. 

Uscom Limited - Annual Report 2012 - 41 

 
 
  
  
  
  
  
  
  
  
  
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
  
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 24: Parent entity information 
Set out below is the supplementary information about the parent entity. 
Statement of comprehensive income 
Loss after income tax credit 
Total comprehensive loss 
Statement of financial position 
Total current assets 
Total assets 
Total current liabilities 
Total liabilities 
Equity 
Contributed equity 
Options reserve 
Accumulated losses 
Total equity 

Parent 

2012 

$ 

2011 

$ 

(1,877,967) 
(1,877,967) 

(2,702,672) 
(2,702,672) 

1,274,021 
1,711,184 
227,635 
354,587 

2,870,703 
3,445,954 
269,424 
367,567 

21,526,920 
1,379,673 
(21,549,996) 
1,356,597 

21,376,920 
1,373,495 
(19,672,028) 
3,078,387 

Contingent liabilities 
The parent entity had no contingent liabilities as at 30 June 2012 and 30 June 2011. 
Capital commitments – Property, plant and equipment 
The parent entity had no capital commitments for property, plant and equipment as at 30 June 2012 and 30 June 
2011. 
Significant accounting policies 
The accounting policies of the parent entity are consistent with those of the consolidated entity, as disclosed in 
note 2. 

Note 25: Commitments 
Operating lease commitments 
Operating commitments represent payments due for office rentals and have an 
average term from 18 to 30 months. 
Less than 1 year 
Between 1 and 5 years 
Total operating commitments 

Note 26: Auditors’ remuneration 
Remuneration of BDO / PKF East Coast Practice for 
Audit of financial report 
Review of financial report 
Non-audit services 
Remuneration of PKF California for 
Tax consulting services 
Total auditors’ remuneration 

Consolidated 

2012 

$ 

2011 

$ 

64,136 
- 
64,136 

39,000 
18,000 
- 

2,956 
59,956 

123,337 
64,136 
187,473 

39,000 
17,000 
2,000 

2,409 
60,409 

Note 27: Operating segments 

Segment information  
The Consolidated Entity operates in the global health and medical products industry.   

The Consolidated Entity sells a single product, the A1 monitor.  Geographical segment reporting is therefore the 
appropriate method of reporting operating segments. 

Globally the Company has five geographic sales and distribution segments as shown below.  For each segment, the 
CEO and CFO / General Manager review internal management reports on at least a monthly basis. 

Uscom Limited - Annual Report 2012 - 42 

 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 27: Operating segments (continued) 

The largest customer group which operates in Asia accounts for 49% of the total sales revenue.  The businesses 2nd 
largest customer accounts for over 17% of the total sales revenues and operates in Europe. 

Basis of accounting for purposes of reporting by operating segments 
Accounting policies 
Segment information is prepared in conformity with the accounting policies of the entity as disclosed in note 2 and 
accounting standard AASB 8 Operating Segments which requires a ‘Management approach’ under which segment 
information is presented on the same basis as that used for internal reporting purposes.   This has resulted in no 
change to the reportable segments as operating segments continue to be reported in a manner consistent with the 
internal reporting provided to the chief operating decision maker, which is the Board of Directors. 

Segment revenues, expenses, assets and liabilities are those that are directly attributable to a segment. Segment 
assets include all assets used by a segment and consist primarily of inventories, property, plant and equipment and 
intangible assets.  While most of these assets can be directly attributable to individual segments, the carrying 
amounts of certain assets used jointly by segments are not allocated.  Segment liabilities consist primarily of trade 
and other creditors, employee benefits and provisions for warranties. Segment assets and liabilities do not include 
deferred income taxes. 

  Australia 

$ 

Asia 

$ 

USA 

Europe 

$ 

$ 

Other 
region 

220 
65,036 

392,266 
- 

150,990 
- 

235,735 
4,928 

14,924 
- 

65,256 

392,266 

150,990 

240,663 

14,924 

Unallocated 

Eliminated  Consolidated 

$ 

- 
- 

- 

$ 

- 
- 

- 

$ 

794,135 
69,964 

864,099 

115 
65,141 
406,253 

134,994 
257,272 
- 

742,031 
(591,041) 
- 

165,171 
75,492 
- 

18,003 
(3,079) 
- 

2,665,478 
(2,665,478) 
- 

(630,893) 
630,893 
- 

3,094,899 
(2,230,800) 
406,253 

2012 
Sales to external 
customers 
Other revenues 
Total segment 
revenues 
Segment 
expenses 
Segment result 
Income tax credit 
Consolidated loss 
from ordinary 
activities after 
income tax credit 

Segment assets 
Segment 
liabilities 

258,407 

422,034 

- 

- 

307,602 

199,970 

3,705 

- 

Acquisition of 
property, plant 
and equipment 
and intangibles 
Impairment of 
patents 
Depreciation and 
amortisation 

17,403 

15,199 

30,011 

21,294 

65,706 

14,791 

- 

- 

52,057 

408 

16,071 

27,769 

- 

- 

- 

- 

- 

(1,824,547) 

1,129,826 

(67,447) 

1,828,358 

- 

(67,447) 

358,292 

- 

- 

7,160 

- 

- 

- 

83,907 

80,497 

103,465 

Uscom Limited - Annual Report 2012 - 43 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOTES TO FINANCIAL STATEMENTS continued 

Note 27: Operating segments (continued) 

  Australia 

$ 

Asia 

$ 

USA 

Europe 

$ 

$ 

Other 
region 

715 
44,505 

291,963 
- 

444,875 
- 

87,026 
1,555 

10,234 
- 

45,220 

291,963 

444,875 

88,581 

10,234 

Unallocated 

Eliminated  Consolidated 

$ 

- 
- 

- 

$ 

- 
- 

- 

$ 

834,813 
46,060 

880,873 

326 
44,894 
344,896 

87,133 
204,830 
- 

1,012,180 
(567,305) 
- 

282,815 
(194,234) 
- 

6,870 
3,364 
- 

3,220,747 
(3,220,747) 
- 

(698,389) 
698,389 
- 

3,911,682 
(3,030,809) 
344,896 

2011 
Sales to external 
customers 
Other revenues 
Total segment 
revenues 
Segment 
expenses 
Segment result 
Income tax credit 
Consolidated loss 
from ordinary 
activities after 
income tax credit 

Segment assets 
Segment 
liabilities 

381,660 

396,903 

- 

- 

254,744 

206,445 

21,118 

- 

Acquisition of 
property, plant 
and equipment 
and intangibles 
Impairment of 
patents 
Depreciation and 
amortisation 

36,595 

12,231 

8,961 

40,153 

- 

11,731 

- 

- 

44,804 

500 

25,386 

25,223 

- 

- 

- 

- 

- 

Note 28: Contingencies 
There were no contingencies as at 30 June 2012. 

(2,685,913) 

2,710,777 

(29,336) 

3,524,290 

- 

(29,336) 

388,685 

- 

- 

7,499 

- 

- 

- 

97,940 

11,731 

103,412 

Note 29: Events after the reporting date 
On 2 July 2012, 2 million shares were issued at 7.5 cents each under a private placement. The issue raised an 
additional $150,000 in new capital and does not require shareholder approval as it is below the limit of 15% of 
issued capital which a company can issue within a 12 month period without shareholder approval per Listing Rule 
7.1.  In August 2012, the company offered to issue 5.8 million shares at 12 cents each raising $696,000 as part of a 
private placement to sophisticated investors.  The offer was over-subscribed.  5.8 million shares which represent 
the balance of the company’s 15% capacity under Listing Rule 7.1 will be issued at the close of the placement and 
any additional shares will be issued subject to shareholder approval.   

Apart from that, no other matters or circumstances have arisen since the end of the financial year to the date of 
this report, that has significantly affected or may significantly affect the activities of the Consolidated Entity, the 
results of those activities or the state of affairs of the Consolidated Entity in the ensuing or any subsequent 
financial year. 

Uscom Limited - Annual Report 2012 - 44 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIREC

CTORS’

’ DECLA

ARATION

N Uscom Lim

mited and its C

Controlled Ent

tity 

In the dire

ectors' opinio

n: 

• 

• 

• 

• 

financial state
the attached f
t
Accounting St
tandards, the 
A
;  
requirements;

ments and no
Corporations 

tes thereto co
Regulations 2

omply with the
2001 and othe

e Corporations
r mandatory p

e 
s Act 2001, the
eporting 
professional re

the attached f
t
Standards as i
S
financial state
f

financial state
issued by the 
ments; 

ments and no
International A

tes thereto co
Accounting St

omply with Inte
tandards Boar

ernational Fin
rd as describe

ancial Reporti
ed in note 2 to

ing 
 the 

t
the attached f
financial posit
f

financial state
tion as at 30 Ju

ments and no
une 2012 and 

tes thereto gi
of its perform

ve a true and 
mance for the f

fair view of th
inancial year e

e consolidate
ended on that

d entity's 
t date; 

t
there are reas
become due a
b

sonable groun
and payable. 

ds to believe 

that the comp

pany will be ab

ble to pay its d

debts as and w

when they 

The direc

ctors have bee

en given the d

eclarations req

quired by sect

tion 295A of t

he Corporatio

ons Act 2001. 

Signed in

n accordance w

with a resoluti

on of director

rs made pursu

ant to section

 295(5) of the 

Corporations

Act 2001. 

On behal

f of the direct

tors 

Rob Philli

ips 

Sheena J

ack 

Executive

e Director - Ch

hairman 

Non-Exe

cutive Directo

or 

Sydney, 3

30 August 201

2 

Uscom Limited 

- Annual Repor

rt 2012 - 45 

 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INDEPENDENT AUDIT REPORT 

Tel: +61 2 9251 4100 
Fax: +61 2 9240 9821 
www.bdo.com.au 

Level 10, 1 Margaret St  
Sydney NSW 2000 
Australia 

INDEPENDENT AUDITOR’S REPORT  

To the members of Uscom Limited 

Report on the Financial Report 

We have audited the accompanying financial report of Uscom Limited, which comprises the 
statement of financial position as at 30 June 2012, the statement of comprehensive income, the 
statement of changes in equity and the statement of cash flows for the year then ended, notes 
comprising a summary of significant accounting policies and other explanatory information, and 
the directors’ declaration of the consolidated entity comprising the company and the entities it 
controlled at the year’s end or from time to time during the financial year.  

Directors’ Responsibility for the Financial Report 

The directors of the company are responsible for the preparation of the financial report that 
gives a true and fair view in accordance with Australian Accounting Standards and the 
Corporations Act 2001 and for such internal control as the directors determine is necessary to 
enable the preparation of the financial report that gives a true and fair view and is free from 
material misstatement, whether due to fraud or error.  In Note 2, the directors also state, in 
accordance with Accounting Standard AASB 101 Presentation of Financial Statements, that the 
financial statements comply with International Financial Reporting Standards. 

Auditor’s Responsibility  

Our responsibility is to express an opinion on the financial report based on our audit. We 
conducted our audit in accordance with Australian Auditing Standards. Those standards require 
that we comply with relevant ethical requirements relating to audit engagements and plan and 
perform the audit to obtain reasonable assurance about whether the financial report is free from 
material misstatement. 

An audit involves performing procedures to obtain audit evidence about the amounts and 
disclosures in the financial report. The procedures selected depend on the auditor’s judgement, 
including the assessment of the risks of material misstatement of the financial report, whether 
due to fraud or error. In making those risk assessments, the auditor considers internal control 
relevant to the company’s preparation of the financial report that gives a true and fair view in 
order to design audit procedures that are appropriate in the circumstances, but not for the 
purpose of expressing an opinion on the effectiveness of the company’s internal control. An audit 
also includes evaluating the appropriateness of accounting policies used and the reasonableness 
of accounting estimates made by the directors, as well as evaluating the overall presentation of 
the financial report. 

BDO East Coast Partnership  ABN 83 236 985 726 is a member of a national association of independent entities which are all members of BDO (Australia) Ltd ABN 
77 050 110 275, an Australian company limited by guarantee. BDO East Coast Partnership and BDO (Australia) Ltd are members of BDO International Ltd, a UK 
company limited by guarantee, and form part of the international BDO network of independent member firms. Liability limited by a scheme approved under 
Professional Standards Legislation (other than for the acts or omissions of financial services licensees) in each State or Territory other than Tasmania. 

Uscom Limited - Annual Report 2012 - 46 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
INDEPENDENT AUDIT REPORT continued 

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a 
basis for our audit opinion.   

Independence 

In conducting our audit, we have complied with the independence requirements of the 
Corporations Act 2001. We confirm that the independence declaration required by the 
Corporations Act 2001, which has been given to the directors of Uscom Limited, would be in the 
same terms if given to the directors as at the time of this auditor’s report. 

Opinion  

In our opinion: 

(a)  the financial report of Uscom Limited is in accordance with the Corporations Act 2001, 

including: 

(i)  giving a true and fair view of the consolidated entity’s financial position as at 30 June 

2012 and of its performance for the year ended on that date; and  

(ii)  complying with Australian Accounting Standards and the Corporations Regulations 2001. 

(b)  the financial report also complies with International Financial Reporting Standards as 

disclosed in Note 2. 

Report on the Remuneration Report  

We have audited the Remuneration Report included in the directors’ report for the year ended 
30 June 2012. The directors of the company are responsible for the preparation and presentation 
of the Remuneration Report in accordance with section 300A of the Corporations Act 2001. Our 
responsibility is to express an opinion on the Remuneration Report, based on our audit conducted 
in accordance with Australian Auditing Standards.  

Opinion  

In our opinion, the Remuneration Report of Uscom Limited for the year ended 30 June 2012 
complies with section 300A of the Corporations Act 2001.  

BDO East Coast Partnership 

Tim Sydenham 
Partner 
Sydney, 30 August 2012 

Uscom Limited - Annual Report 2012 - 47 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SHAREHOLDER INFORMATION 

Additional information required by Australian Stock Exchange Listing Rules is as follows. This information is 
current as at 31 July 2012. 

(a)  Distribution Schedules of Shareholder 
Holdings Ranges 

1 – 1,000 
1,001 – 5,000 
5,001 – 10,000 
10,001 – 100,000 
100,001 – 99,999,999,999 

Total 

Holders 
Number 
112 
208 
76 
118 
44 

558 

Ordinary shares 
Number 
80,749 
619,718 
606,082 
4,268,734 
48,549,205 

54,124,488 

% 
0.149 
1.145 
1.120 
7.887 
89.699 

100 

There were 269 holders of less than a marketable parcel of 451,871 ordinary shares. 

(b)  Class of shares and voting rights 
All shares are ordinary shares. Each ordinary share is entitled to one vote when a poll is called, otherwise each 
member present at a meeting or by proxy has one vote on a show of hands. 

Substantial shareholders 

(c) 
The names of the substantial shareholders listed in the holding company’s register as at 31 July 2012 are: 

Robert Allan Phillips 
Gary Desmond Davey 
Dr Stephen Frederick Woodford 
DRP Cartons (NSW) Pty Ltd   

16,996,733 
6,219,000 
3,459,590 
2,175,458 

(d)  Twenty largest registered holders – ordinary shares 

Balance as at 31 July 2012 

Robert Allan Phillips 
Gary Desmond Davey 
Dr Stephen Frederick Woodford 
DRP Cartons (NSW) Pty Ltd   
Bell Potter Nominees Ltd  
Merrill Lynch (Australia) Nominees Pty Limited 
Stream Group Holdings Pty Ltd 
Invia Custodian Pty Limited  
Arinya Investments Pty Ltd 
Stream Group Aust Pty Ltd 
Mr Rutherford James Browne & Mrs Sheba Elizabeth Marjorie Browne 
Mr Alister John Forsyth 
Gailforce Marketing & PR Pty Ltd  
Apollan Pty Ltd 
DRP Cartons (NSW) Pty Ltd 
Jules Flach 
Ross Planning Pty Ltd  
Dr Russell Kay Hancock 
Citicorp Nominees Pty Limited 
Hinona Pty Ltd  

Ordinary 
shares 
Number 
16,996,733 
6,219,000 
3,459,590 
2,175,458 
2,124,836 
2,014,982 
2,000,000 
1,688,118 
1,050,000 
954,111 
829,792 
768,809 
553,809 
547,700 
507,876 
500,000 
421,269 
400,800 
375,535 
357,159 

% 
31.40% 
11.49% 
6.39% 
4.02% 
3.93% 
3.72% 
3.70% 
3.12% 
1.94% 
1.76% 
1.53% 
1.42% 
1.02% 
1.01% 
0.94% 
0.93% 
0.78% 
0.74% 
0.69% 
0.66% 

Total 

43,945,577 

81.19% 

Uscom Limited - Annual Report 2012 - 48 

 
 
 
 
 
 
 
 
 
 
 
 
SHAREHOLDER INFORMATION continued 

Registered office and principal place of office 
Level 7, 10 Loftus Street 
Sydney NSW 2000 Australia 
Tel: 
Fax: 

02 9247 4144 
02 9247 8157 

Company Secretary 
Tom Rowe 

Registers of securities 
Boardroom Pty Limited 

Level 7, 207 Kent Street 
Sydney NSW 2000 Australia 

GPO Box 3993 
Sydney NSW 2001 Australia 

1300 737 760 
Tel:  
Fax: 
1300 653 459 
www.boardroomlimited.com.au 

Stock exchange listing 
Quotation has been granted for 54,124,488 ordinary shares of the Company on all Member Exchanges of the 
Australian Stock Exchange Limited. 

Unquoted securities 
Options over unissued shares 
A total of 3,560,000 options over ordinary shares are on issue. 2,000,000 options are on issue to OSI System. and 
1,560,000 options are on issue to ten employees and executives under the Uscom Employee Share Option Plan 
and Uscom Executive Share Option Plan. 

Uscom Limited - Annual Report 2012 - 49 

 
 
 
 
 
 
 
 
 
Uscom Ltd, Suite 1, Level 7, 10 Loftus Street, Sydney NSW 2000 Australia T +612 9247 4144